{"content":"<li class=\"n-box-item date-title\" data-end=\"1476417599\" data-start=\"1476331200\" data-txt=\"Sunday, December 22, 2019\">Thursday, October 13, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3213941\" data-ts=\"1476399147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWER\" target=\"_blank\">TWER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213941-towerstream-forecasts-100-buildings-added-to-network-in-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Towerstream forecasts 100 buildings added to network in Q4</a></h4><ul>    <li>Fixed wireless firm Towerstream (<a href=\"https://seekingalpha.com/symbol/TWER-OLD\" title=\"Towerstream Corporation\">TWER</a> <font color=\"red\">-1.6%</font>) says today that it's projecting to add 100 buildings to its On-Net footprint in Q4, a 22% gain from Q3.</li>    <li>The move would bring its On-Net total to 437 buildings by the end of the quarter, and put the total number of businesses in the footprint over 13,000 (up 30% Q/Q).</li>    <li>\u201cThere is a direct relationship in sales growth to the number of buildings On-Net,\u201d says interim CEO Philip Urso.</li>    <li>\n<a href=\"https://seekingalpha.com/news/3201912-towerstream-recovering-plus-3_1-percent-q2-earnings\" target=\"_blank\">In its Q2</a>, the company posted revenues that fell 2.3% Y/Y, but On-Net customers grew 48% Q/Q (with 71% of those secondary installs).</li>    <li>When installed, September contracts are expected to total more than $780,000 in annualized revenue.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213941\" data-linked=\"Towerstream forecasts 100 buildings added to network in Q4\" data-tweet=\"$TWER $TWER-OLD - Towerstream forecasts 100 buildings added to network in Q4 https://seekingalpha.com/news/3213941-towerstream-forecasts-100-buildings-added-to-network-in-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3213941-towerstream-forecasts-100-buildings-added-to-network-in-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213940\" data-ts=\"1476399059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGLT\" target=\"_blank\">EGLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213940-fda-informs-egalet-tomorrows-action-date-for-arymo-er-wont-be-met-shares-down-12-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA informs Egalet that tomorrow&#39;s action date for ARYMO ER won&#39;t be met; shares down 12% after hours</a></h4><ul>\n<li>Thinly traded micro cap Egalet (<a href=\"https://seekingalpha.com/symbol/EGLT\" title=\"Egalet Ltd.\">OTC:EGLT</a>) is off <font color=\"red\">12%</font> after hours on increased volume in response to its announcement that there will be no decision by the FDA tomorrow, the PDUFA date, regarding its New Drug Application (NDA) seeking approval of ARYMO ER (morphine sulfate) for the management of severe pain. The company says the FDA informed it that it needs more time to review the filing, as they have done with other abuse-deterrent opioid NDAs. The agency added that no additional data or scientific information are needed for the application.</li>\n<li>On August 4, the FDA Advisory Committee voted 18 - 1 in favor of approval.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213940\" data-linked=\"FDA informs Egalet that tomorrow&#39;s action date for ARYMO ER won&#39;t be met; shares down 12% after hours\" data-tweet=\"$EGLT $ZCOR - FDA informs Egalet that tomorrow&#39;s action date for ARYMO ER won&#39;t be met; shares down 12% after hours https://seekingalpha.com/news/3213940-fda-informs-egalet-tomorrows-action-date-for-arymo-er-wont-be-met-shares-down-12-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3213940-fda-informs-egalet-tomorrows-action-date-for-arymo-er-wont-be-met-shares-down-12-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>55&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213929\" data-ts=\"1476395794\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STRZA\" target=\"_blank\">STRZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213929-lions-gate-prices-starz-merger-financing-lower-expected-rates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lions Gate prices Starz merger financing at lower-than-expected rates</a></h4><ul>   <li>Lions Gate Entertainment (<a href=\"https://seekingalpha.com/symbol/LGF\" target=\"_blank\">LGF</a> <font color=\"red\">-3%</font>) has <a href=\"http://www.prnewswire.com/news-releases/lionsgate-announces-pricing-of-520-million-of-senior-notes-and-allocation-of-20-billion-term-loan-b-credit-facility-300344661.html\" target=\"_blank\">priced $520M in senior notes</a> and allocated loans under a $2B facility.</li>    <li>The company priced the $520M in debt at an interest rate of 5.875% -- lower than the 7.5% rate assumed in the company's pro forma statements reflecting its proposed tie-up with Starz (<a href=\"https://seekingalpha.com/symbol/STRZA\" title=\"Starz\">STRZA</a> <font color=\"red\">-1.1%</font>).</li>    <li>It also said loans have been allocated under its $2B term loan B facility, which it expects to be issued at 99.5% and bear interest at Libor plus 3% (with a Libor floor of 0.75%). The pro forma statements had assumed that loan would be issued for $1.9B at 100% and at interest of Libor plus 3.75%.</li>    <li>The loans are set to fund part of the company's merger with Starz.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213929\" data-linked=\"Lions Gate prices Starz merger financing at lower-than-expected rates\" data-tweet=\"$STRZA $STRZA $LGF.A - Lions Gate prices Starz merger financing at lower-than-expected rates https://seekingalpha.com/news/3213929-lions-gate-prices-starz-merger-financing-lower-expected-rates?source=tweet\" data-url=\"https://seekingalpha.com/news/3213929-lions-gate-prices-starz-merger-financing-lower-expected-rates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213927\" data-ts=\"1476394505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213927-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/MUX' title='McEwen Mining Inc.'>MUX</a> <font color='green'>+3.9%</font>. <a href='https://seekingalpha.com/symbol/ERIC' title='LM Ericsson Telephone Company'>ERIC</a> <font color='green'>+2.0%</font>. <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='green'>+2.2%</font>. <a href='https://seekingalpha.com/symbol/COT' title='Cott Corporation'>COT</a> <font color='green'>+1.8%</font>. <a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a> <font color='green'>+1.3%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/HIVE' title='Aerohive Networks, Inc.'>HIVE</a> <font color='red'>-16.5%</font>. <a href='https://seekingalpha.com/symbol/NHTC' title='Natural Health Trends Corp.'>NHTC</a> <font color='red'>-13.3%</font>. <a href='https://seekingalpha.com/symbol/RSPP' title='RSP Permian'>RSPP</a> <font color='red'>-4.9%</font>. <a href='https://seekingalpha.com/symbol/FSM' title='Fortuna Silver Mines'>FSM</a> <font color='red'>-3.2%</font>. <a href='https://seekingalpha.com/symbol/DTK' title='Deutsche Bank Contingent Cap Tr I'>DTK</a> <font color='red'>-3.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213927\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$MUX $ERIC $MT - After Hours Gainers / Losers https://seekingalpha.com/news/3213927-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3213927-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213923\" data-ts=\"1476393600\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NHTC\" target=\"_blank\">NHTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213923-natural-health-trends-announces-q3-preliminary-revenue-estimate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural Health Trends announces Q3 preliminary revenue estimate</a></h4><ul>     <li>Natural Health Trends (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NHTC\" title=\"Natural Health Trends Corp.\">NHTC</a>) estimates total revenue for Q3 to be $70.7M (-12% Y/Y).</li>     <li>President Chris Sharng: \"The special measures the Chinese government implemented to prepare for the G20 Summit in Hangzhou, one of our top markets, such as temporarily relocating city residents, emptying entire districts, blocking urban traffic and shutting down businesses in July, August and early September adversely impacted our local members\u2019 abilities to organize any activity in that metropolitan area, Another negative effect on our revenue came from the Yuan\u2019s 6% depreciation against the Hong Kong dollar, effectively increasing the product pricing in the currency of our Chinese members.\u201d</li>\n<li>Shares <font color=\"red\">-12.5% AH</font>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213923\" data-linked=\"Natural Health Trends announces Q3 preliminary revenue estimate\" data-tweet=\"$NHTC - Natural Health Trends announces Q3 preliminary revenue estimate https://seekingalpha.com/news/3213923-natural-health-trends-announces-q3-preliminary-revenue-estimate?source=tweet\" data-url=\"https://seekingalpha.com/news/3213923-natural-health-trends-announces-q3-preliminary-revenue-estimate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213920\" data-ts=\"1476392492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFC\" target=\"_blank\">WFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213920-wells-fargo-closes-lower-after-stumpf-exits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo closes lower after Stumpf exits</a></h4><ul><li>Along with some other sell-siders, <a href=\"https://www.thestreet.com/story/13852575/1/wells-fargo-wfc-ceo-stumpf-s-retirement-beginning-of-the-end-clsa-s-mayo-says.html?utm_campaign=breakingnews&amp;utm_source=twitter&amp;utm_medium=social\" target=\"_blank\">Mike Mayo is supportive</a> of John Stumpf's exit from the bank and the elevation of Tim Sloan to CEO, but says further changes need to be made.</li><li>Speaking to CNBC, Sloan says a number of significant changes are already in motion, among them management and the incentive compensation system.</li><li>\"Everyone wanted to have someone's head on a plate and now they do,\" <a href=\"http://www.cnbc.com/2016/10/13/john-stumpf-resignation-doesnt-end-headaches-for-wells-fargo-or-other-wall-street-banks.html\" target=\"_blank\">says KBW's&nbsp;Brian Kleinhanzl</a>. \"Now that he's gone, you go on to the next discussion.\"</li><li>Wells Fargo (NYSE:<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a>) reports its Q3 tomorrow before the bell. Analysts are looking for EPS of $1.01 on $22.22B in revenue vs. $1.05 and $21.88B a year ago.</li><li>The stock was unable to hold onto gains and closed&nbsp;<font color='red'>lower today by 1.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3213920\" data-linked=\"Wells Fargo closes lower after Stumpf exits\" data-tweet=\"$WFC - Wells Fargo closes lower after Stumpf exits https://seekingalpha.com/news/3213920-wells-fargo-closes-lower-after-stumpf-exits?source=tweet\" data-url=\"https://seekingalpha.com/news/3213920-wells-fargo-closes-lower-after-stumpf-exits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213909\" data-ts=\"1476392323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPQ\" target=\"_blank\">HPQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213909-hpminus-2_2-after-hours-fy-2017-outlook-issued-restructuring-filed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HP -2.2% after hours; FY 2017 outlook issued, restructuring filed</a></h4><ul>\n<li>Projects EPS at $1.55-$1.65 (<a href=\"https://www.bloomberg.com/news/articles/2016-10-13/hp-inc-to-cut-up-to-4-000-jobs-over-three-years-amid-pc-slump\" target=\"_blank\">consensus $1.61</a>) and free cash flow at $2.3B-$2.6B.</li>\n<li>Quarterly dividend raised 7%, additional $3B share repurchase authorized.</li>\n<li>Anticipates returning 50%-75% of free cash flow through dividends and buy backs.</li>\n<li>HP (NYSE:<a href=\"https://seekingalpha.com/symbol/HPQ\" title=\"HP Inc.\">HPQ</a>) president and CEO Dion Weisler: \"Although our markets remain very challenged, we are committed to innovating in the core and continue to see long-term growth opportunities in commercial mobility and services, the disruption of the A3 copier market, and the digitization of graphics and manufacturing through our leading 3D printing solutions.\"</li>\n<li>In a separate <a href=\"http://hsprod.investis.com/shared/v2/irwizard/sec_item_new.jsp?epic=hewlett_packard&amp;ipage=11179727&amp;DSEQ=&amp;SEQ=&amp;SQDESC=\" target=\"_blank\">8-K filing</a>, HP discloses a 3K-4K employee restructuring expected to be implemented starting in FY 2017 through FY 2019. Estimates a $200M-$300M range for gross annual run rate savings beginning in FY 2020, though $350M-$500M in overall charges resulting from the plan.</li>\n<li><a href=\"http://h30261.www3.hp.com/news-and-events/hp-investor-events/upcoming-events/13-10-2016.aspx\" target=\"_blank\">Conference call</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213909\" data-linked=\"HP -2.2% after hours; FY 2017 outlook issued, restructuring filed\" data-tweet=\"$HPQ - HP -2.2% after hours; FY 2017 outlook issued, restructuring filed https://seekingalpha.com/news/3213909-hpminus-2_2-after-hours-fy-2017-outlook-issued-restructuring-filed?source=tweet\" data-url=\"https://seekingalpha.com/news/3213909-hpminus-2_2-after-hours-fy-2017-outlook-issued-restructuring-filed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213914\" data-ts=\"1476391627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RSPP\" target=\"_blank\">RSPP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213914-rsp-permian-to-buy-silver-hill-energy-partners-in-2_4b-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RSP Permian to buy Silver Hill Energy Partners in $2.4B deal</a></h4><ul>     <li>RSP Permian (NYSE:<a href=\"https://seekingalpha.com/symbol/RSPP\" title=\"RSP Permian\">RSPP</a>) <font color=\"red\">-5.8%</font> AH after agreeing to acquire Silver Hill Energy Partners and Silver Hill E&amp;P II for  $1.25B in cash and 31M common shares of its common stock, implying a  total purchase price of ~$2.4B.</li>\n<li>RSPP says the deal is a unique acquisition of a highly contiguous acreage position in the core of the Delaware Basin with 41K net surface acres, which creates substantial scale with combined current production of  ~50K boe/day, 100K-plus net surface acres, 500K-plus  net effective horizontal acres, and 3,600 net drilling locations  with substantial additional upside.</li>     <li>To help fund the deal, RSPP launches a 20M-share public offering, with an underwriters option to purchase up to an additional 3M common shares.</li>\n<li>Silver Hill reportedly had <a href=\"https://seekingalpha.com/news/3211888-wsj-diamondback-energy-near-deal-buy-silver-hill-2_5b\" target=\"_blank\">attracted interest</a> from the likes of Diamondback Energy (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FANG\" title=\"Diamondback Energy\">FANG</a>), Noble Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/NBL\" title=\"Noble Energy, Inc.\">NBL</a>), Marathon Oil (NYSE:<a href=\"https://seekingalpha.com/symbol/MRO\" title=\"Marathon Oil Corporation\">MRO</a>) and Occidental Petroleum (NYSE:<a href=\"https://seekingalpha.com/symbol/OXY\" title=\"Occidental Petroleum Corporation\">OXY</a>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213914\" data-linked=\"RSP Permian to buy Silver Hill Energy Partners in $2.4B deal\" data-tweet=\"$RSPP $RSPP $FANG - RSP Permian to buy Silver Hill Energy Partners in $2.4B deal https://seekingalpha.com/news/3213914-rsp-permian-to-buy-silver-hill-energy-partners-in-2_4b-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3213914-rsp-permian-to-buy-silver-hill-energy-partners-in-2_4b-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213912\" data-ts=\"1476391265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAA\" target=\"_blank\">UAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213912-under-armour-zumiez-higher-after-piper-upgrades-estee-lauder-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Under Armour, Zumiez higher after Piper upgrades; Estee Lauder cut</a></h4><ul>\n<li>Following Piper Jaffray's annual \"Taking Stock With Teens\" survey, analyst <a href=\"http://thefly.com/landingPageNews.php?id=2443962&amp;headline=UA;EL;ZUMZ-Under-Armour-upgraded-to-Overweight-after-teen-survey-at-Piper-Jaffray\" target=\"_blank\">Erinn Murphy upgrades</a> Under Armour (NYSE:<a href=\"https://seekingalpha.com/symbol/UA\" title=\"Under Armour, Inc. Class C\">UA</a>) to Overweight from Neutral, saying the findings show on-going traction for the company in the footwear and women's segments.</li>\n<li>The price target is boosted to $44 from $40 (today's close was $38.18).</li>\n<li>Also based on the survey results, Zumiez (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ZUMZ\" title=\"Zumiez Inc.\">ZUMZ</a>) is lifted to Overweight from Neutral, and Estee Lauder (NYSE:<a href=\"https://seekingalpha.com/symbol/EL\" title=\"Estee Lauder Companies, Inc. (The)\">EL</a>) is downgraded to Neutral from Overweight.</li>\n<li>UA <font color=\"green\">+2.15%</font>, ZUMZ <font color=\"green\">+3.15%</font>, EL <font color=\"red\">-0.2%</font> after hours</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213912\" data-linked=\"Under Armour, Zumiez higher after Piper upgrades; Estee Lauder cut\" data-tweet=\"$UAA $UAA $ZUMZ - Under Armour, Zumiez higher after Piper upgrades; Estee Lauder cut https://seekingalpha.com/news/3213912-under-armour-zumiez-higher-after-piper-upgrades-estee-lauder-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3213912-under-armour-zumiez-higher-after-piper-upgrades-estee-lauder-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213905\" data-ts=\"1476390674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENZ\" target=\"_blank\">ENZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213905-enzo-biochem-fiscal-q4-top-line-up-4-non-gaap-net-loss-narrows-shares-up-6-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enzo Biochem fiscal Q4 top line up 4%; non-GAAP net loss narrows; shares up 6% after hours</a></h4><ul>\n<li>Enzo Biochem (NYSE:<a href=\"https://seekingalpha.com/symbol/ENZ\" title=\"Enzo Biochem, Inc.\">ENZ</a>) fiscal Q4 results ($M): Revenues: 26.6 (+3.5%); Net Income: 36.1 (+329.8%); Non-GAAP Net Income: (1.9) (+25.6%); EPS: 0.77 (+327.8%).</li>\n<li>\n<strong>Fiscal 2016 result</strong><strong>s</strong>: Revenues: 102.8 (+5.3%); Net Income: 45.3 (+999%); Non-GAAP Net Income: (9.2) (+31.5%); EPS: 0.97 (+999%).</li>\n<li>GAAP earnings include $38.8M from settlements related to patent litigation.</li>\n<li>Shares are up <font color=\"green\">6%</font> on light volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213905\" data-linked=\"Enzo Biochem fiscal Q4 top line up 4%; non-GAAP net loss narrows; shares up 6% after hours\" data-tweet=\"$ENZ - Enzo Biochem fiscal Q4 top line up 4%; non-GAAP net loss narrows; shares up 6% after hours https://seekingalpha.com/news/3213905-enzo-biochem-fiscal-q4-top-line-up-4-non-gaap-net-loss-narrows-shares-up-6-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3213905-enzo-biochem-fiscal-q4-top-line-up-4-non-gaap-net-loss-narrows-shares-up-6-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213884\" data-ts=\"1476388961\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKYAY\" target=\"_blank\">SKYAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213884-murdoch-confirmed-sky-chairman-despite-30-opposition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Murdoch confirmed as Sky chairman despite 30% opposition</a></h4><ul>   <li>James Murdoch was confirmed as chairman of Sky (<a href=\"https://seekingalpha.com/symbol/SKYAY\" title=\"Sky Plc ADR\">OTCPK:SKYAY</a> <font color=\"red\">-1.7%</font>) today, but not without a <a href=\"http://www.reuters.com/article/us-sky-plc-agm-murdoch-idUSKCN12D251\" target=\"_blank\">heavy opposition contingent</a>.</li>    <li>Nearly 30% of shareholders opposed the appointment of Murdoch on grounds that he's too close to Rupert Murdoch -- his father, tied to Twenty-First Century Fox (<a href=\"https://seekingalpha.com/symbol/FOX\" title=\"Twenty-First Century Fox, Inc.\">FOX</a>, <a href=\"https://seekingalpha.com/symbol/FOXA\" title=\"Twenty-First Century Fox, Inc.\">FOXA</a>), which owns 39% of Sky.</li>    <li>Other boardmembers were approved with 90%-plus margins.</li>    <li>No attempts were made to advertise the position externally, said Royal London's Piers Hillier, and: \"Should Fox make a bid for Sky, investors need a strong independent chairman to protect the interests of minority shareholders and negotiate the best possible deal.\"</li>    <li>The company says it will engage with opposed shareholders even as it says the board's decision to reappoint James Murdoch was unanimous.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213884\" data-linked=\"Murdoch confirmed as Sky chairman despite 30% opposition\" data-tweet=\"$SKYAY $SKYAY $FOX - Murdoch confirmed as Sky chairman despite 30% opposition https://seekingalpha.com/news/3213884-murdoch-confirmed-sky-chairman-despite-30-opposition?source=tweet\" data-url=\"https://seekingalpha.com/news/3213884-murdoch-confirmed-sky-chairman-despite-30-opposition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213886\" data-ts=\"1476388778\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAV-OLD\" target=\"_blank\">AAV-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213886-advantage-oil-says-new-eight-well-montney-pad-exceeds-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Advantage Oil says new eight well Montney pad exceeds expectations</a></h4><ul>     <li>Advantage Oil &amp; Gas (<a href=\"https://seekingalpha.com/symbol/AAV-OLD\" title=\"Advantage Oil &amp; Gas Ltd.\">AAV-OLD</a> <font color=\"green\">+2.4%</font>) is higher after its Q3 operational update included a <a href=\"https://www.sec.gov/Archives/edgar/data/1468079/000127956916004478/ex991.pdf\" target=\"_blank\">44% Y/Y increase in production</a> to 215M cfe/day.</li>     <li>AAV says a new Glacier eight well Montney pad was completed and outperformed expectations with a combined initial production flow rate of 120M cf/day.</li>\n<li>The eight well pad was designed to evaluate increased frac stages,  longer horizontal laterals and cost efficiencies related to continued  optimization of well operations and larger pad sizes, specifically in  the Lower and Middle Montney formations.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213886\" data-linked=\"Advantage Oil says new eight well Montney pad exceeds expectations\" data-tweet=\"$AAV-OLD - Advantage Oil says new eight well Montney pad exceeds expectations https://seekingalpha.com/news/3213886-advantage-oil-says-new-eight-well-montney-pad-exceeds-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3213886-advantage-oil-says-new-eight-well-montney-pad-exceeds-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213869\" data-ts=\"1476385274\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213869-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/VLTC' title='Voltari Corporation'>OTC:VLTC</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/NTNX' title='Nutanix'>NTNX</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/QBAK' title='Qualstar Corporation'>QBAK</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/BOSC' title='B.O.S. Better Online Solutions'>BOSC</a> <font color='green'>+6%</font>. MIFI <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CUB' title='Cubic Corporation'>CUB</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/VNET' title='21Vianet Group'>VNET</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/PDVW' title='pdvWireless, Inc.'>PDVW</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/SIMO' title='Silicon Motion Technology Corporation'>SIMO</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213869\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$VLTC $NTNX $QBAK - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3213869-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3213869-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213867\" data-ts=\"1476385176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTSH\" target=\"_blank\">CTSH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213867-cognizant-technology-solutions-infosys-aided-tata-consultancy-services-profit-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cognizant Technology Solutions, Infosys aided by Tata Consultancy Services profit beat</a></h4><ul>\n<li>Cognizant Technology Solutions (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CTSH\" title=\"Cognizant Technology Solutions Corporation\">CTSH</a>) is <font color=\"green\">up 2.3%</font> while Infosys (NASDAQ:<a href=\"https://seekingalpha.com/symbol/INFY\" title=\"Infosys Limited, Inc.\">INFY</a>) is <font color=\"green\">higher by 4.2%</font> subsequent Tata Consultancy Services posting <a href=\"http://www.bloomberg.com/news/articles/2016-10-13/tata-consultancy-profit-beats-estimates-amid-push-into-cloud\" target=\"_blank\">better-than-projected Q3 profit</a> despite \"caution among customers\", \"holdbacks in discretionary spending\" and other industry headwinds. Lower revenue, however, is considered indicative of increasing competition and rigorous market conditions.</li>\n<li>Infosys to report Q2 results early tomorrow, Cognizant expected to report on November 2.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213867\" data-linked=\"Cognizant Technology Solutions, Infosys aided by Tata Consultancy Services profit beat\" data-tweet=\"$CTSH $CTSH $INFY - Cognizant Technology Solutions, Infosys aided by Tata Consultancy Services profit beat https://seekingalpha.com/news/3213867-cognizant-technology-solutions-infosys-aided-tata-consultancy-services-profit-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3213867-cognizant-technology-solutions-infosys-aided-tata-consultancy-services-profit-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213863\" data-ts=\"1476384442\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOG\" target=\"_blank\">HOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213863-harley-davidson-swings-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harley-Davidson swings higher</a></h4><ul>     <li>Harley-Davidson (NYSE:<a href='https://seekingalpha.com/symbol/HOG' title='Harley-Davidson, Inc.'>HOG</a>) has fought all the way back from an early 3% drop tied to a M Science warning on quarterly trends.</li>     <li>In a separate development from the M Science note, Harley CEO Matthew Levatich says he is <a href=\"http://www.cnbc.com/2016/10/13/early-movers-dal-wfc-pfe-csx-k-hog-nok-dltr-five-more.html\" target=\"_blank\">optimistic</a> about expanding the firm's business in both existing and new Asian markets.</li><li>Harley is now&nbsp;<font color='green'>up 1.04%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213863\" data-linked=\"Harley-Davidson swings higher\" data-tweet=\"$HOG - Harley-Davidson swings higher https://seekingalpha.com/news/3213863-harley-davidson-swings-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3213863-harley-davidson-swings-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213860\" data-ts=\"1476384137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHK\" target=\"_blank\">CHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213860-chesapeake-energy-maintained-sell-ubs-debt-load-still-too-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chesapeake Energy maintained as a Sell at UBS, with debt load still too high</a></h4><ul>     <li>Chesapeake Energy (<a href=\"https://seekingalpha.com/symbol/CHK\" title=\"Chesapeake Energy Corporation\">CHK</a> <font color=\"green\">+1.7%</font>) is higher even as UBS <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/10/13/chesapeake-energy-the-debts-still-just-too-darn-high/\" target=\"_blank\">reaffirms its Sell rating</a> on the stock, saying the company\u2019s debt load remains too high.</li>     <li>UBS says CHK's liquidity position has improved, principal debt has been reduced by more than $1B YTD, and 2017 debt maturities have been cut by two thirds to $658M, but it believes financial leverage remains \"far too high,\" and the company needs to explain at its upcoming analyst day - its first since May 2014 - how it plans to reduce debt by $2B-$3B over the next few years.</li>\n<li>UBS says even assuming CHK can achieve $3B of asset sales in 2017-18, the firm estimates it still would have net debt/EBITDA of greater than 4x at year-end 2018 under its price deck and before volumes associated with a deal.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213860\" data-linked=\"Chesapeake Energy maintained as a Sell at UBS, with debt load still too high\" data-tweet=\"$CHK - Chesapeake Energy maintained as a Sell at UBS, with debt load still too high https://seekingalpha.com/news/3213860-chesapeake-energy-maintained-sell-ubs-debt-load-still-too-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3213860-chesapeake-energy-maintained-sell-ubs-debt-load-still-too-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213857\" data-ts=\"1476383654\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VZ\" target=\"_blank\">VZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213857-reuters-verizon-gc-says-reasonable-basis-to-think-yahoo-hack-is-material-to-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Verizon GC says &#39;reasonable basis&#39; to think Yahoo hack is material to deal</a></h4><ul>   <li>The general counsel at Verizon (NYSE:<a href=\"https://seekingalpha.com/symbol/VZ\" title=\"Verizon Communications\">VZ</a>) is now saying there's a \"reasonable basis\" to believe that a massive data breach at Yahoo (YHOO) had a material impact on Verizon's $4.83B takeover agreement, Reuters reports.</li>    <li>Yahoo shares are headed down, <font color=\"red\">now -1.8%</font>. <a href=\"https://seekingalpha.com/symbol/VZ\" title=\"Verizon Communications\">VZ</a> is flat on the day.</li>\n<li>The comment adds some fuel to speculation that Verizon could look to change up the existing deal, or even get out of it.</li>    <li>A <em>New York Post</em> report last week suggested that Verizon would <a href=\"https://seekingalpha.com/news/3212866-new-york-post-verizon-seek-1b-discount-4_83b-yahoo-deal\" target=\"_blank\">seek up to a $1B discount</a> on the purchase price, with sources saying Verizon's Tim Armstrong was getting some \"cold feet.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213857\" data-linked=\"Reuters: Verizon GC says &#39;reasonable basis&#39; to think Yahoo hack is material to deal\" data-tweet=\"$VZ $VZ $AABA - Reuters: Verizon GC says &#39;reasonable basis&#39; to think Yahoo hack is material to deal https://seekingalpha.com/news/3213857-reuters-verizon-gc-says-reasonable-basis-to-think-yahoo-hack-is-material-to-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3213857-reuters-verizon-gc-says-reasonable-basis-to-think-yahoo-hack-is-material-to-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213856\" data-ts=\"1476383584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213856-u-s-steelminus-5_5-hot-rolled-coil-prices-slide-below-500-ton\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel -5.5% as hot rolled coil prices slide below $500/ton</a></h4><ul>     <li>Even without the latest <a href=\"https://seekingalpha.com/news/3213693-china-exports-dive-september\" target=\"_blank\">gloomy export data from China</a>, shares of U.S. Steel (<a href=\"https://seekingalpha.com/symbol/X\" title=\"United States Steel Corporation\">X</a> <font color=\"red\">-5.5%</font>) might have dropped because of <a href=\"http://www.amm.com/Article/3590656/Steel-prices-expected-to-fall-into-2017-Moodys.html\" target=\"_blank\">falling steel prices</a>.</li>     <li>Axiom Capital\u2019s Gordon Johnson says U.S. hot rolled coil steel prices have dropped to $496/ton, below \u201cthe psychologically [important] $500 threshold... this is <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/10/13/u-s-steel-uh-oh/\" target=\"_blank\">not good for U.S. steel mills</a>.\u201d</li>     <li>Also: <a href=\"https://seekingalpha.com/symbol/SLX\" title=\"VanEck Vectors Steel ETF\">SLX</a> <font color=\"red\">-2.9%</font>, <a href=\"https://seekingalpha.com/symbol/MT\" title=\"ArcelorMittal\">MT</a> <font color=\"red\">-2.3%</font>, <a href=\"https://seekingalpha.com/symbol/AKS\" title=\"AK Steel Holding Corp\">AKS</a> <font color=\"red\">-4.2%</font>, <a href=\"https://seekingalpha.com/symbol/STLD\" title=\"Steel Dynamics, Inc.\">STLD</a> <font color=\"red\">-1.9%</font>, <a href=\"https://seekingalpha.com/symbol/RS\" title=\"Reliance Steel &amp; Aluminum Co.\">RS</a> <font color=\"red\">-1.7%</font>, <a href=\"https://seekingalpha.com/symbol/ATI\" title=\"Allegheny Technologies Incorporated\">ATI</a> <font color=\"red\">-3%</font>, <a href=\"https://seekingalpha.com/symbol/WOR\" title=\"Worthington Industries, Inc.\">WOR</a> <font color=\"red\">-1.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213856\" data-linked=\"U.S. Steel -5.5% as hot rolled coil prices slide below $500/ton\" data-tweet=\"$X $X $SLX - U.S. Steel -5.5% as hot rolled coil prices slide below $500/ton https://seekingalpha.com/news/3213856-u-s-steelminus-5_5-hot-rolled-coil-prices-slide-below-500-ton?source=tweet\" data-url=\"https://seekingalpha.com/news/3213856-u-s-steelminus-5_5-hot-rolled-coil-prices-slide-below-500-ton\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213855\" data-ts=\"1476383101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIA\" target=\"_blank\">VIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213855-viacom-gains-bofa-wells-fargo-upgrade-on-improving-prospects\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viacom gains as BofA, Wells Fargo upgrade on improving prospects</a></h4><ul>   <li>Viacom (<a href=\"https://seekingalpha.com/symbol/VIA\" title=\"Viacom Inc.\">VIA</a> <font color=\"green\">+1.9%</font>, <a href=\"https://seekingalpha.com/symbol/VIAB\" title=\"Viacom Inc.\">VIAB</a> <font color=\"green\">+1.8%</font>) is moving up today as analysts raise their takes with discussion centered on the prospect of the company's potential reunion with CBS (<a href=\"https://seekingalpha.com/symbol/CBS\" title=\"CBS Corporation\">CBS</a> <font color=\"green\">+0.4%</font>).</li>    <li>Bank of America Merrill Lynch boosted the stock two notches to Buy, noting its low valuation and the possible remarriage, but analyst Jessica Reif Cohen says it may take some time for her enthusiasm to pan out. Even without a re-merger, new management (and some restructuring, possibly including asset sales) bodes well for the company's prospects.</li>    <li>She boosted her price target on <a href=\"https://seekingalpha.com/symbol/VIAB\" title=\"Viacom Inc.\">VIAB</a> to $44 from $37, implying 23% upside.</li>    <li>Wells Fargo also upgraded, to Market Perform from a previous Underperform. Analyst Marci Ryvicker sees <a href=\"http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Wells+Fargo+Upgrades+Viacom+%28VIAB%29+to+Market+Perform/12128440.html\" target=\"_blank\">less downside to Viacom</a> these days, though she too doesn't necessarily think a merger is close.</li>    <li>\"A CBS-VIAB combo does not appear imminent,\" she writes. \"But if/when it does happen, we don\u2019t see CBS paying less than $32-33 in a take-under, which doesn\u2019t present much downside risk (we downgraded VIAB to Underperform on 7/10).</li>    <li>\"The one piece we believe people are missing is incremental programming cost in a VIAB turnaround--we forecast AT LEAST $250MM, which offsets a lot of our initial $400MM synergy est. We cut VIAB ests &amp; reduced the val. range to $33-35. BUT, we upgrade to Market Perform as we believe we\u2019re close to the pot\u2019l floor.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213855\" data-linked=\"Viacom gains as BofA, Wells Fargo upgrade on improving prospects\" data-tweet=\"$VIA $VIA $VIAB - Viacom gains as BofA, Wells Fargo upgrade on improving prospects https://seekingalpha.com/news/3213855-viacom-gains-bofa-wells-fargo-upgrade-on-improving-prospects?source=tweet\" data-url=\"https://seekingalpha.com/news/3213855-viacom-gains-bofa-wells-fargo-upgrade-on-improving-prospects\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213854\" data-ts=\"1476382959\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MENT\" target=\"_blank\">MENT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213854-mentor-graphicsplus-2-advisor-on-strategic-alternatives-reportedly-hired\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mentor Graphics +2%, advisor on strategic alternatives reportedly hired</a></h4><ul>\n<li>Elliot Management had <a href=\"https://seekingalpha.com/news/3211676-elliott-management-discloses-8_1-percent-active-stake-mentor-graphics\" target=\"_blank\">doubled an active stake</a> in Mentor Graphics (<a href=\"https://seekingalpha.com/symbol/MENT\" title=\"Mentor Graphics Corporation\">MENT</a> <font color=\"green\">+1.9%</font>) late in September, noting several operational and strategic opportunities existed to improve shareholder value.</li>\n<li>Developing.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213854\" data-linked=\"Mentor Graphics +2%, advisor on strategic alternatives reportedly hired\" data-tweet=\"$MENT - Mentor Graphics +2%, advisor on strategic alternatives reportedly hired https://seekingalpha.com/news/3213854-mentor-graphicsplus-2-advisor-on-strategic-alternatives-reportedly-hired?source=tweet\" data-url=\"https://seekingalpha.com/news/3213854-mentor-graphicsplus-2-advisor-on-strategic-alternatives-reportedly-hired\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213853\" data-ts=\"1476382602\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213853-energy-materials-top-5-gainers-losers-of-2-10-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:10 pm</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ECR' title='Eclipse Resources'>ECR</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/GLF' title='GulfMark Offshore, Inc.'>GLF</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/AKG' title='Asanko Gold Inc.'>AKG</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/GST' title='Gastar Exploration Inc.'>GST</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> LEI <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/SNMX' title='Senomyx, Inc.'>SNMX</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/LXU' title='LSB Industries, Inc.'>LXU</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/FELP' title='Foresight Energy LP'>FELP</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/CGA' title='China Green Agriculture, Inc.'>CGA</a> <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3213853\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:10 pm\" data-tweet=\"$ECR-OLD $GLF $AKG - Energy/Materials - Top 5 Gainers / Losers as of 2:10 pm https://seekingalpha.com/news/3213853-energy-materials-top-5-gainers-losers-of-2-10-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3213853-energy-materials-top-5-gainers-losers-of-2-10-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213851\" data-ts=\"1476382066\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIG\" target=\"_blank\">FIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213851-fortress-mulls-sale-of-florida-east-coast-railway-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fortress mulls sale of Florida East Coast Railway - Bloomberg</a></h4><ul>\n<li>Fortress Investment Group (NYSE:<a href=\"https://seekingalpha.com/symbol/FIG\" title=\"Fortress Investment Group LLC\">FIG</a>) took the coastal freight operator private in a $3.5B deal in 2007, and has hired Barclays and Morgan Stanley to explore options, <a href=\"http://www.bloomberg.com/news/articles/2016-10-13/fortress-said-to-explore-sale-of-florida-east-coast-railway?utm_content=deals&amp;utm_campaign=socialflow-organic&amp;utm_source=twitter&amp;utm_medium=social&amp;cmpid%3D=socialflow-twitter-deals\" target=\"_blank\">write Ed Hammond and Kiel Porter at Bloomberg</a>.</li>\n<li>Fortress later spun off the railway operations into a separate company, leaving the real estate, logistics, and telecom assets under the original parent umbrella.</li>\n<li>The news has sent FIG shooting <font color=\"green\">3.5% higher</font> in the past few minutes.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213851\" data-linked=\"Fortress mulls sale of Florida East Coast Railway - Bloomberg\" data-tweet=\"$FIG - Fortress mulls sale of Florida East Coast Railway - Bloomberg https://seekingalpha.com/news/3213851-fortress-mulls-sale-of-florida-east-coast-railway-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3213851-fortress-mulls-sale-of-florida-east-coast-railway-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213948\" data-ts=\"1476381450\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPH\" target=\"_blank\">SPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213948-suburban-propane-raised-to-buy-stifel-on-potential-for-colder-winter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Suburban Propane raised to Buy at Stifel on potential for colder winter</a></h4><ul>     <li>Suburban Propane Partners (<a href=\"https://seekingalpha.com/symbol/SPH\" title=\"Suburban Propane Partners LP\">SPH</a> <font color=\"green\">+2.9%</font>) is <a href=\"http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Stifel+Raises+Suburban+Propane+%28SPH%29+to+Buy+on+Potenital+for+Colder+Winter/12128498.html\" target=\"_blank\">upgraded to Buy</a> from Hold with a $36 price target, up from $34, at Stifel, tied in part to expectations for a colder winter.</li>     <li>Following a review of historical propane volume trends and associated heating degree days, the firm expresses a growing confidence that SPH will experience modestly improved volumes in the upcoming winter heating  season based on EIA's Short Term Energy Outlook.</li>\n<li>Noting that the EIA historically has proven very accurate  on average in predicting upcoming winter heating demand, Stifel views SPH's current valuation as attractive given potential EBITDA generation on a modest uptick in heating degree days.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3213948\" data-linked=\"Suburban Propane raised to Buy at Stifel on potential for colder winter\" data-tweet=\"$SPH - Suburban Propane raised to Buy at Stifel on potential for colder winter https://seekingalpha.com/news/3213948-suburban-propane-raised-to-buy-stifel-on-potential-for-colder-winter?source=tweet\" data-url=\"https://seekingalpha.com/news/3213948-suburban-propane-raised-to-buy-stifel-on-potential-for-colder-winter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213849\" data-ts=\"1476380806\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CXRX-OLD\" target=\"_blank\">CXRX-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213849-concordia-lower-4_45-debt-sale-closes-adds-board-member\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Concordia lower by 4.45% as debt sale closes; adds board member</a></h4><ul>\n<li>The company will pay 9% annually for $350M of 5.5-year paper which sold at par. The closing of the sale marks the \"formal conclusion\" of Concordia's (<a href=\"https://seekingalpha.com/symbol/CXRX-OLD\" title=\"Concordia International Corp\">CXRX-OLD</a> <font color=\"red\">-4.2%</font>) strategic review.</li>\n<li>Added to the board is Allan Oberman, who was CEO of Sagent Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SGNT\" title=\"Sagent Pharmaceuticals\">SGNT</a>) until its sale at the end of August.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213849\" data-linked=\"Concordia lower by 4.45% as debt sale closes; adds board member\" data-tweet=\"$CXRX-OLD $CXRX-OLD $SGNT - Concordia lower by 4.45% as debt sale closes; adds board member https://seekingalpha.com/news/3213849-concordia-lower-4_45-debt-sale-closes-adds-board-member?source=tweet\" data-url=\"https://seekingalpha.com/news/3213849-concordia-lower-4_45-debt-sale-closes-adds-board-member\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>77&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213946\" data-ts=\"1476380745\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFG\" target=\"_blank\">NFG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213946-national-fuel-gas-raised-to-buy-added-to-franchise-picks-list-jefferies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">National Fuel Gas raised to Buy, added to Franchise Picks List at Jefferies</a></h4><ul>     <li>National Fuel Gas (<a href=\"https://seekingalpha.com/symbol/NFG\" title=\"National Fuel Gas Co.\">NFG</a> <font color=\"green\">+2.7%</font>) is <a href=\"http://www.streetinsider.com/Analyst+Comments/Jefferies+Upgrades+National+Fuel+Gas+%28NFG%29+to+Buy%3B+Added+to+Franchise+Picks+List/12128325.html\" target=\"_blank\">upgraded to Buy</a> from Hold with a $67 price target, raised from $60, at Jefferies, which also adds the stock to its Franchise Picks List.</li>     <li>The firm cites a roll-forward to 2018 financial expectations and the incorporation of Northern Access-related growth, and notes that shares are down ~10% in the last month in sympathy with broader utility sector weakness.</li>     <li>Despite the recent uptick in political opposition to new energy pipelines, Jefferies believes NFG\u2019s Northern Access project stands a good chance of securing the necessary approvals for its November 2017 planned in-service date and will significantly advance the company\u2019s value proposition.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213946\" data-linked=\"National Fuel Gas raised to Buy, added to Franchise Picks List at Jefferies\" data-tweet=\"$NFG - National Fuel Gas raised to Buy, added to Franchise Picks List at Jefferies https://seekingalpha.com/news/3213946-national-fuel-gas-raised-to-buy-added-to-franchise-picks-list-jefferies?source=tweet\" data-url=\"https://seekingalpha.com/news/3213946-national-fuel-gas-raised-to-buy-added-to-franchise-picks-list-jefferies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213843\" data-ts=\"1476379052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BNFT\" target=\"_blank\">BNFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213843-benefitfocus-lower-ceo-sells-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Benefitfocus lower as CEO sells shares</a></h4><ul><li>CEO Shawn Jenkins hit the bid on Monday, <a href=\"https://www.sec.gov/Archives/edgar/data/1576169/000120919116145731/xslF345X03/doc4.xml\" target=\"_blank\">selling 10K shares</a> at $42.03 each.</li><li><a href='https://seekingalpha.com/symbol/BNFT' title='Benefitfocus, Inc.'>BNFT</a>&nbsp;<font color='red'>-4.9%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3213843\" data-linked=\"Benefitfocus lower as CEO sells shares\" data-tweet=\"$BNFT - Benefitfocus lower as CEO sells shares https://seekingalpha.com/news/3213843-benefitfocus-lower-ceo-sells-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3213843-benefitfocus-lower-ceo-sells-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213832\" data-ts=\"1476378696\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSM\" target=\"_blank\">TSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213832-taiwan-semiconductor-manufacturing-company-highlights-smartphone-demand-in-q3-report-raises\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taiwan Semiconductor Manufacturing Company highlights smartphone demand in Q3 report, raises forecast</a></h4><ul>\n<li>TSMC (NYSE:<a href=\"https://seekingalpha.com/symbol/TSM\" title=\"Taiwan Semiconductor Manufacturing Company Ltd.\">TSM</a>) recorded 22.5% Y/Y, 17.4% Q/Q revenue (NT $260.41B) growth and 28.4% Y/Y, 33.4% Q/Q growth in net income (NT$96.76B).</li>\n<li>Gross margin came in at 50.7%, operating margin 40.8% and net profit margin 37.2%.</li>\n<li>16/20-nanometer shipments comprised 31% of wafer revenue, 28-nanometer process technology accounted for 24% (28nm combined with other advanced technologies represented 55%).</li>\n<li>TSMC SVP and CFO Lora Ho: \"Despite a less favorable exchange rate than our forecast, third quarter revenue surpassed the high-end of our guidance given three months ago, mainly due to strong demand in overall smartphone market.\"</li>\n<li>Projections for Q4 \u2013 Revenue of NT$255B-NT$258B (11%-12% growth vs. 5%-10% previously guided), gross profit margin of 50.5%-52.5%, operating profit margin of 40%-42% and capital budget of $9.5B.</li>\n<li>Taiwan Semiconductor Manufacturing Company is <a href=\"http://www.reuters.com/article/us-tsmc-results-idUSKCN12D0IM\" target=\"_blank\">considered</a> to be the exclusive manufacturer of A10 chips used in Apple's (<a href=\"https://seekingalpha.com/symbol/AAPL\" title=\"Apple Inc.\">AAPL</a> <font color=\"red\">-0.6%</font>) iPhone 7 and 7 Plus, and although a supplier to other smartphone makers, the results appear to indicate positively for those devices.</li>\n<li>On upcoming inventory reduction level concern sparked during the company's conference call, however, TSMC shares are <font color=\"red\">lower today by 4%</font>. Co-CEO Mark Liu: \"The previously anticipated inventory reduction at the end of Q4 will be mild. The end of this year will be more peaceful than in previous years. We see end-market demand is still healthy.\"</li>\n<li><a href=\"https://seekingalpha.com/article/4011884-taiwan-semiconductor-manufacturing-company-ltd-2016-q3-results-earnings-call-slides\" target=\"_blank\">Earnings slides</a></li>\n<li><a href=\"http://www.tsmc.com/uploadfile/ir/quarterly/2016/3tBfm/E/FS.pdf\" target=\"_blank\">Financial statements</a></li>\n<li><a href=\"http://www.tsmc.com/uploadfile/ir/quarterly/2016/3tBfm/E/3Q16ManagementReport.pdf\" target=\"_blank\">Management report</a></li>\n<li><a href=\"http://wms.gridow.com/ir/tsmc/tsmc_2016Q3.html\" target=\"_blank\">Conference call</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213832\" data-linked=\"Taiwan Semiconductor Manufacturing Company highlights smartphone demand in Q3 report, raises forecast\" data-tweet=\"$TSM $TSM $AAPL - Taiwan Semiconductor Manufacturing Company highlights smartphone demand in Q3 report, raises forecast https://seekingalpha.com/news/3213832-taiwan-semiconductor-manufacturing-company-highlights-smartphone-demand-in-q3-report-raises?source=tweet\" data-url=\"https://seekingalpha.com/news/3213832-taiwan-semiconductor-manufacturing-company-highlights-smartphone-demand-in-q3-report-raises\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213838\" data-ts=\"1476378294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213838-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AIII' title='ACRE Realty Investors Inc.'>AIII</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AAMC' title='Altisource Asset Management Corp'>AAMC</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/FNBC' title='First NBC Bank Holding Company'>OTC:FNBC</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/FRC' title='First Republic Bank'>FRC</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213838\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$AIII $AAMC $FNBC - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3213838-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3213838-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213830\" data-ts=\"1476377255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213830-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/AEZS\" title=\"AEterna Zentaris, Inc.\">AEZS</a> <font color=\"green\">+17%</font>. <a href=\"https://seekingalpha.com/symbol/OCUL\" title=\"Ocular Therapeutix\">OCUL</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/CTRV\" title=\"ContraVir Pharmaceuticals, Inc.\">CTRV</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/LNN\" title=\"Lindsay Corporation\">LNN</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/NTLA\" title=\"Intellia Therapeutics\">NTLA</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/ESNC\" title=\"EnSync, Inc.\">ESNC</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/FVE\" title=\"Five Star Senior Living, Inc.\">FVE</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/ULTA\" title=\"Ulta Beauty, Inc.\">ULTA</a> <font color=\"green\">+11%</font>. LTEA <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/GNCA\" title=\"Genocea Biosciences, Inc.\">GNCA</a> <font color=\"green\">+10%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/FLDM\" title=\"Fluidigm Corporation\">FLDM</a> <font color=\"red\">-27%</font>. <a href=\"https://seekingalpha.com/symbol/FLKS\" title=\"Flex Pharma\">FLKS</a> <font color=\"red\">-21%</font>. <a href=\"https://seekingalpha.com/symbol/CVTI\" title=\"Covenant Transportation Group, Inc.\">CVTI</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/TGTX\" title=\"TG Therapeutics, Inc.\">TGTX</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/OPTT\" title=\"Ocean Power Technologies, Inc.\">OPTT</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/NSPR\" title=\"InspireMD, Inc.\">NSPR</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/CLSD\" title=\"Clearside Biomedical\">CLSD</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/VNET\" title=\"21Vianet Group\">VNET</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/DPRX\" title=\"Dipexium Pharmaceuticals, LLC\">DPRX</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/AAMC\" title=\"Altisource Asset Management Corp\">AAMC</a> <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213830\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$AEZS $OCUL $HEPA - Midday Gainers / Losers https://seekingalpha.com/news/3213830-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3213830-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213827\" data-ts=\"1476376729\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RACE\" target=\"_blank\">RACE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213827-ferrari-looks-expensive-to-societe-generale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ferrari looks expensive to Societe Generale</a></h4><ul>\n<li>Ferrari (<a href=\"https://seekingalpha.com/symbol/RACE\" title=\"Ferrari N.V.\">RACE</a> <font color=\"red\">-1.1%</font>) is lower after Societe Generale starts off coverage on the high-end automaker with a Sell rating on valuation concerns.</li>\n<li>The French firm assigns a $45 price target on Ferrari.</li>\n<li>Ferrari trades on the top end of its 52-week range of $31.66 to $60.97. SA contributor Josh Arnold was in with a <a href=\"https://seekingalpha.com/article/4008703-ferrari-making-valuation-call\" target=\"_blank\">valuation warning</a> a few weeks ago.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213827\" data-linked=\"Ferrari looks expensive to Societe Generale\" data-tweet=\"$RACE - Ferrari looks expensive to Societe Generale https://seekingalpha.com/news/3213827-ferrari-looks-expensive-to-societe-generale?source=tweet\" data-url=\"https://seekingalpha.com/news/3213827-ferrari-looks-expensive-to-societe-generale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213824\" data-ts=\"1476375525\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIO\" target=\"_blank\">RIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213824-rio-tinto-and-bhp-weighed-gloomy-china-data-citi-downgrade-to-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rio Tinto and BHP weighed by gloomy China data, Citi downgrade to Sell</a></h4><ul>     <li>Iron ore heavyweights Rio Tinto (<a href=\"https://seekingalpha.com/symbol/RIO\" title=\"Rio Tinto plc\">RIO</a> <font color=\"red\">-3.4%</font>) and BHP Billiton (<a href=\"https://seekingalpha.com/symbol/BHP\" title=\"BHP Billiton Limited\">BHP</a> <font color=\"red\">-3.5%</font>) are sharply lower following the news that <a href=\"https://seekingalpha.com/news/3213693-china-exports-dive-september\" target=\"_blank\">Chinese exports</a> fell by a more than expected 10% and imports dropped by a more than anticipated 1.9%.</li>\n<li>Also down substantially are the likes of Freeport McMoRan (<a href=\"https://seekingalpha.com/symbol/FCX\" title=\"Freeport-McMoRan Inc.\">FCX</a> <font color=\"red\">-6.5%</font>), U.S. Steel (<a href=\"https://seekingalpha.com/symbol/X\" title=\"United States Steel Corporation\">X</a> <font color=\"red\">-5.7%</font>), Teck Resources (TCK <font color=\"red\">-5.4%</font>), Cliffs Natural Resources (<a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs, Inc.\">CLF</a> <font color=\"red\">-5%</font>), Anglo American (<a href=\"https://seekingalpha.com/symbol/AAUKF\" title=\"Anglo American plc\">OTCQX:AAUKF</a>, <a href=\"https://seekingalpha.com/symbol/AAUKY\" title=\"Anglo American plc ADR\">OTCPK:AAUKY</a>) and Glencore (<a href=\"https://seekingalpha.com/symbol/GLCNF\" title=\"Glencore Plc\">OTCPK:GLCNF</a>, <a href=\"https://seekingalpha.com/symbol/GLNCY\" title=\"Glencore Plc ADR\">OTCPK:GLNCY</a>).</li>     <li>Also, Rio and BHP are <a href=\"http://blogs.barrons.com/emergingmarketsdaily/2016/10/13/citi-downgrades-rio-bhp-to-sell-miners-sink/\" target=\"_blank\">downgraded to Sell</a> from Neutral at Citigroup, which cites the impact of slack China commodities demand after the country's monetary stimulus and supply restrictions have driven a surge in bulk prices in 2016.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213824\" data-linked=\"Rio Tinto and BHP weighed by gloomy China data, Citi downgrade to Sell\" data-tweet=\"$RIO $RIO $BHP - Rio Tinto and BHP weighed by gloomy China data, Citi downgrade to Sell https://seekingalpha.com/news/3213824-rio-tinto-and-bhp-weighed-gloomy-china-data-citi-downgrade-to-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/3213824-rio-tinto-and-bhp-weighed-gloomy-china-data-citi-downgrade-to-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213822\" data-ts=\"1476374738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRO\" target=\"_blank\">GPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213822-j-p-morgan-unconcerned-on-gopros-amazon-shipments-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.P. Morgan unconcerned on GoPro&#39;s Amazon shipments [updated]</a></h4><ul>\n<li>\n<a href=\"http://www.streetinsider.com/Analyst+Comments/JPMorgan+Defends+GoPro+%28GPRO%29+on+Sell-Off/12129940.html\" target=\"_blank\">Considers</a> today's move lower on <a href=\"https://seekingalpha.com/news/3213737-gopro-minus-3_85-percent-pre-piper-says-amazon-ditched\" target=\"_blank\">notes</a> GoPro (<a href=\"https://seekingalpha.com/symbol/GPRO\" title=\"GoPro\">GPRO</a> <font color=\"red\">-2.3%</font>) won't be shipping to Amazon in the U.S. for what is expected to be the entire month of October, a buying opportunity.</li>\n<li>Analyst Paul Coster sees the Amazon channel re-establishing in November, and estimates that if Amazon comprises 10% of sales, a one-month hiatus would represent 30K units or around $10M.</li>\n<li>Reissues GoPro rating at Overweight with a $16 price target (current price $14).</li>\n<li>\n<strong>Update (2PM ET)</strong>: Dougherty &amp; Company and Raymond James <a href=\"http://blogs.barrons.com/techtraderdaily/2016/10/13/gopro-face-off-dougherty-raymond-james-defend-hero-5-sales/\" target=\"_blank\">aren't overly troubled</a> by the situation either.<b><br></b>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213822\" data-linked=\"J.P. Morgan unconcerned on GoPro&#39;s Amazon shipments [updated]\" data-tweet=\"$GPRO - J.P. Morgan unconcerned on GoPro&#39;s Amazon shipments [updated] https://seekingalpha.com/news/3213822-j-p-morgan-unconcerned-on-gopros-amazon-shipments-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3213822-j-p-morgan-unconcerned-on-gopros-amazon-shipments-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213821\" data-ts=\"1476374603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213821-consumer-goods-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Goods - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> LTEA <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/REED' title='Reed&#39;s, Inc.'>REED</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/VOXX' title='VOXX International Corp.'>VOXX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/FENX' title='Fenix Parts'>OTC:FENX</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a> <font color='red'>-7%</font>. XNY <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3213821\" data-linked=\"Consumer Goods - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$LBCC $REED $VOXX - Consumer Goods - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3213821-consumer-goods-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3213821-consumer-goods-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213812\" data-ts=\"1476373263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLND\" target=\"_blank\">TLND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213812-talendplus-10-on-goldman-sachs-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Talend +10% on Goldman Sachs upgrade</a></h4><ul>\n<li>\n<a href=\"http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Goldman+Sachs+Upgrades+Talend+SA+%28TLND%29+to+Buy/12128458.html\" target=\"_blank\">From</a> Neutral to Buy.</li>\n<li>Price target kept at $31 (current price $24.31).</li>\n<li>Talend shares (<a href=\"https://seekingalpha.com/symbol/TLND\" title=\"Talend SA\">TLND</a> <font color=\"green\">+10.1%</font>), factoring in today's gains, are nevertheless <font color=\"red\">down 10%</font> on the month and <font color=\"red\">4% </font>since the company went public in late July.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213812\" data-linked=\"Talend +10% on Goldman Sachs upgrade\" data-tweet=\"$TLND - Talend +10% on Goldman Sachs upgrade https://seekingalpha.com/news/3213812-talendplus-10-on-goldman-sachs-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3213812-talendplus-10-on-goldman-sachs-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213811\" data-ts=\"1476373142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGF.A\" target=\"_blank\">LGF.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213811-lions-gate-extends-deal-ceo-feltheimer-to-2023\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lions Gate extends deal with CEO Feltheimer to 2023</a></h4><ul>   <li>Lions Gate Entertainment (<a href=\"https://seekingalpha.com/symbol/LGF\" target=\"_blank\">LGF</a> <font color='red'>-2.1%</font>) has <a href=\"https://www.sec.gov/Archives/edgar/data/929351/000092935116000109/a8-kfeltheimeragreementame.htm\" target=\"_blank\">extended its contract</a> with CEO Jon Feltheimer through 2023, a five-year extension of his current deal.</li>    <li>That adds another seven years beyond today to the 16 he has spent running the company so far. During that time, the company says it's grown into a global content leader with a film slate averaging almost $2B annually in worldwide box office as well as a TV business encompassing nearly 80 series on 40 networks.</li>    <li>Feltheimer gets an annual base salary of $1.5M and has a target bonus at 100% of base. Along with stock options, he also has a bonus opportunity for $5M depending on performance goals tied to the pending acquisition of Starz.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213811\" data-linked=\"Lions Gate extends deal with CEO Feltheimer to 2023\" data-tweet=\"$LGF.A - Lions Gate extends deal with CEO Feltheimer to 2023 https://seekingalpha.com/news/3213811-lions-gate-extends-deal-ceo-feltheimer-to-2023?source=tweet\" data-url=\"https://seekingalpha.com/news/3213811-lions-gate-extends-deal-ceo-feltheimer-to-2023\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213808\" data-ts=\"1476371390\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IP\" target=\"_blank\">IP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213808-containerboard-pricing-worries-hit-paper-sector-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Containerboard pricing worries hit paper sector again</a></h4><ul>\n<li>Paper stock are showing some weakness on concerns raised by Cleveland Research on containerboard pricing.</li>\n<li>International Paper (<a href=\"https://seekingalpha.com/symbol/IP\" title=\"International Paper Co.\">IP</a> <font color=\"red\">-1.9%</font>), WestRock (<a href=\"https://seekingalpha.com/symbol/WRK\" title=\"WestRock Company\">WRK</a> <font color=\"red\">-3.1%</font>), KapStone Paper and Packaging (<a href=\"https://seekingalpha.com/symbol/KS\" title=\"KapStone Paper and Packaging Corporation\">KS</a> <font color=\"red\">-2.8%</font>), Clearwater Paper (<a href=\"https://seekingalpha.com/symbol/CLW\" title=\"Clearwater Paper Corporation\">CLW</a> <font color=\"red\">-1.5%</font>), and Packaging Corp of America (<a href=\"https://seekingalpha.com/symbol/PKG\" title=\"Packaging Corporation Of America\">PKG</a> <font color=\"red\">-2.2%</font>) are all lower.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3212560-paper-stocks-slump-pricing-anxiety\" target=\"_blank\">Paper stocks slump on pricing anxiety</a> (Oct. 5)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213808\" data-linked=\"Containerboard pricing worries hit paper sector again\" data-tweet=\"$IP $IP $WRK - Containerboard pricing worries hit paper sector again https://seekingalpha.com/news/3213808-containerboard-pricing-worries-hit-paper-sector-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3213808-containerboard-pricing-worries-hit-paper-sector-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213807\" data-ts=\"1476371370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SO\" target=\"_blank\">SO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213807-southern-s-kemper-county-clean-coal-plant-produces-first-power\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Southern\u2019s Kemper County clean coal plant produces first power</a></h4><ul>     <li>Southern Co. (<a href=\"https://seekingalpha.com/symbol/SO\" title=\"Southern Company\">SO</a> <font color=\"green\">+1.5%</font>) subsidiary Mississippi power says its Kemper County clean coal power plant produced its first electricity generated by synthetic natural gas converted from lignite coal.</li>     <li>The $6.9B facility's first power generation is a <a href=\"http://www.bloomberg.com/news/articles/2016-10-13/southern-s-6-9-billion-clean-coal-plant-produces-first-power\" target=\"_blank\">major step toward starting full commercial operations</a> after years of delays and cost overruns; once in service, Kemper County will be the first large-scale power plant in the U.S. to gasify coal and capture carbon before being released into the atmosphere.</li>\n<li>Mississippi Power expects the project to be placed in service by Nov. 30.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213807\" data-linked=\"Southern\u2019s Kemper County clean coal plant produces first power\" data-tweet=\"$SO - Southern\u2019s Kemper County clean coal plant produces first power https://seekingalpha.com/news/3213807-southern-s-kemper-county-clean-coal-plant-produces-first-power?source=tweet\" data-url=\"https://seekingalpha.com/news/3213807-southern-s-kemper-county-clean-coal-plant-produces-first-power\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213806\" data-ts=\"1476371085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213806-crude-inventory-builds-sharply-after-decline-in-previous-weeks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude inventory builds sharply after decline in previous weeks</a></h4><ul>\n<li>\n<a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories</a>:</li>\n<li>Crude <strong>+4.9</strong><strong>M</strong> barrels vs. +0.7M consensus, -3M last week.</li>\n<li>Gasoline <strong>-1.9</strong><strong>M</strong> barrels vs. -1.5M consensus, +0.2M last week.</li>\n<li>Distillates <strong>-3.7M</strong> barrels vs. -1.6M consensus, -2.4M last week.</li>\n<li>Futures <font color=\"red\">-1.1%</font> to $49.65.</li>\n<li>ETFs:<a href=\"https://seekingalpha.com/symbol/USO\" title=\"The United States Oil ETF, LP\">USO</a>,                                    <a href=\"https://seekingalpha.com/symbol/OIL\" title=\"iPath S&amp;P Crude Oil Total Return Index ETN\">OIL</a>, <a href=\"https://seekingalpha.com/symbol/UCO\" title=\"ProShares Ultra Bloomberg Crude Oil ETF\">UCO</a>, <a href=\"https://seekingalpha.com/symbol/SCO\" title=\"ProShares UltraShort Bloomberg Crude Oil ETF\">SCO</a>, <a href=\"https://seekingalpha.com/symbol/BNO\" title=\"The United States Brent Oil ETF, LP\">BNO</a>,        <a href=\"https://seekingalpha.com/symbol/DTO\" title=\"DB Crude Oil Double Short ETN\">DTO</a>,          <a href=\"https://seekingalpha.com/symbol/DBO\" title=\"PowerShares DB Oil ETF\">DBO</a>,           <a href=\"https://seekingalpha.com/symbol/UWTI\" title=\"VelocityShares 3x Long Crude Oil ETN\">UWTI</a>,          <a href=\"https://seekingalpha.com/symbol/USL\" title=\"The United States 12 Month Oil ETF, LP\">USL</a>,        <a href=\"https://seekingalpha.com/symbol/DWTI\" title=\"VelocityShares 3x Inverse Crude Oil ETN\">DWTI</a>,  <a href=\"https://seekingalpha.com/symbol/DNO\" title=\"The United States Short Oil ETF, LP\">DNO</a>,         <a href=\"https://seekingalpha.com/symbol/SZO\" title=\"DB Crude Oil Short ETN\">SZO</a>,  <a href=\"https://seekingalpha.com/symbol/OLO\" title=\"DB Crude Oil Long ETN\">OLO</a>,          <a href=\"https://seekingalpha.com/symbol/OLEM\" title=\"iPath Pure Beta Crude Oil ETN\">OLEM</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213806\" data-linked=\"Crude inventory builds sharply after decline in previous weeks\" data-tweet=\"$USO $OIL $UCO - Crude inventory builds sharply after decline in previous weeks https://seekingalpha.com/news/3213806-crude-inventory-builds-sharply-after-decline-in-previous-weeks?source=tweet\" data-url=\"https://seekingalpha.com/news/3213806-crude-inventory-builds-sharply-after-decline-in-previous-weeks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213805\" data-ts=\"1476371076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HDP\" target=\"_blank\">HDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213805-hortonworks-downgraded-to-sell-goldman-sachsminus-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hortonworks downgraded to Sell at Goldman Sachs; -5%</a></h4><ul>\n<li>\n<a href=\"http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Goldman+Sachs+Downgrades+Hortonworks+%28HDP%29+to+Sell/12128454.html\" target=\"_blank\">From</a> a previous Buy rating.</li>\n<li>Analyst Jesse Hulsing: \"Our initial Buy thesis of ongoing Hadoop adoption sustaining growth and improved efficiency due to a higher mix of expansions has been wrong. Moving forward, we see risks to both near-term estimates and to HDP\u2019s longer-term growth profile. As such, we lower our FY17/FY18 sales estimates, which are now 0.2%/9% below consensus. The combination of these factors leads us to believe HDP will underperform our Emerging Software Attractive coverage view.\"</li>\n<li>Price target lowered on Hortonworks (<a href=\"https://seekingalpha.com/symbol/HDP\" title=\"Hortonworks\">HDP</a> <font color=\"red\">-5.2%</font>) from $13 to $7 (current price $7.08).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213805\" data-linked=\"Hortonworks downgraded to Sell at Goldman Sachs; -5%\" data-tweet=\"$HDP - Hortonworks downgraded to Sell at Goldman Sachs; -5% https://seekingalpha.com/news/3213805-hortonworks-downgraded-to-sell-goldman-sachsminus-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3213805-hortonworks-downgraded-to-sell-goldman-sachsminus-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213803\" data-ts=\"1476370842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213803-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/CTRV\" title=\"ContraVir Pharmaceuticals, Inc.\">CTRV</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/AEZS\" title=\"AEterna Zentaris, Inc.\">AEZS</a> <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/OCUL\" title=\"Ocular Therapeutix\">OCUL</a> <font color=\"green\">+17%</font>. <a href=\"https://seekingalpha.com/symbol/ESPR\" title=\"Esperion Therapeutics\">ESPR</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/NTLA\" title=\"Intellia Therapeutics\">NTLA</a> <font color=\"green\">+10%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/FLDM\" title=\"Fluidigm Corporation\">FLDM</a> <font color=\"red\">-25%</font>. <a href=\"https://seekingalpha.com/symbol/FLKS\" title=\"Flex Pharma\">FLKS</a> <font color=\"red\">-22%</font>. <a href=\"https://seekingalpha.com/symbol/NSPR\" title=\"InspireMD, Inc.\">NSPR</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/TGTX\" title=\"TG Therapeutics, Inc.\">TGTX</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/ACIU\" title=\"AC Immune SA\">ACIU</a> <font color=\"red\">-9%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213803\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$HEPA $AEZS $OCUL - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3213803-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3213803-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213800\" data-ts=\"1476370217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVX\" target=\"_blank\">CVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213800-bloomberg-indias-ongc-among-bidders-for-chevrons-bangladesh-assets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: India&#39;s ONGC among bidders for Chevron&#39;s Bangladesh assets</a></h4><ul>     <li>Top Indian oil and gas explorer Oil &amp; Natural Gas Corp. and Hong Kong-listed United Energy are <a href=\"http://www.bloomberg.com/news/articles/2016-10-13/ongc-united-energy-said-to-vie-for-2-billion-chevron-fields\" target=\"_blank\">among the bidders</a> for Bangladesh natural gas fields being sold by Chevron (<a href=\"https://seekingalpha.com/symbol/CVX\" title=\"Chevron Corporation\">CVX</a> <font color=\"red\">-1.6%</font>), Bloomberg reports.</li>     <li>The assets, which <a href=\"https://seekingalpha.com/news/3213410-bloomberg-chevron-seeking-2b-sale-bangladesh-assets\" target=\"_blank\">could fetch as much as $2B</a>, also have attracted interest from Brightoil Petroleum and the Bangladesh government, according to the report.</li>     <li>CVX operates the Bibiyana, Jalalabad and Moulavi Bazar natural gas fields in Bangladesh, with last year's production averaging 720M cf/day of natural gas and 3K bbl/day of condensate.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213800\" data-linked=\"Bloomberg: India&#39;s ONGC among bidders for Chevron&#39;s Bangladesh assets\" data-tweet=\"$CVX - Bloomberg: India&#39;s ONGC among bidders for Chevron&#39;s Bangladesh assets https://seekingalpha.com/news/3213800-bloomberg-indias-ongc-among-bidders-for-chevrons-bangladesh-assets?source=tweet\" data-url=\"https://seekingalpha.com/news/3213800-bloomberg-indias-ongc-among-bidders-for-chevrons-bangladesh-assets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213791\" data-ts=\"1476369734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESPR\" target=\"_blank\">ESPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213791-esperion-adds-patients-on-statin-therapy-to-bempedoic-acids-phase-3-development-program-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Esperion adds patients on statin therapy to bempedoic acid&#39;s Phase 3 development program after positive Phase 2 results; shares up 11%</a></h4><ul>\n<li>Esperion Therapeutics (<a href=\"https://seekingalpha.com/symbol/ESPR\" title=\"Esperion Therapeutics\">ESPR</a> <font color=\"green\">+10.5%</font>) perks up in early trading in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1434868/000110465916149912/a16-19801_1ex99d1.htm\" target=\"_blank\">announcement</a> that patients with hypercholesterolemia (elevated LDL-C) who are being treated with any dose of statins will be included in its Phase 3 development program for bempedoic acid. A pivotal trial, CLEAR LDL-C, should commence by year end with top-line results expected in mid-2018. If all goes well, regulatory submissions will follow in H1 2019.</li>\n<li>Its decision was based on positive top-line results from its eight-week Phase 2 study of bempedoic acid added to atorvastatin (Pfizer's (<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a> <font color=\"red\">-0.9%</font>) <a href=\"http://www.lipitor.com/\" target=\"_blank\">LIPITOR</a>) which showed a 22% reduction in LDL-C from baseline compared to placebo (p=0.0028) against a background of atorvastatin in all subjects. The administration of bempedoic acid also produced a 35% reduction in C-reactive protein, a biomarker of cardiovascular disease-related inflammation.</li>\n<li>\n<a href=\"http://www.esperion.com/therapies-progress/etc-1002/\" target=\"_blank\">Bempedoic acid</a> is a small molecule that lowers cholesterol without the side effects associated with statins. Once in the liver, it converts into a derivative coenzyme which directly inhibits an enzyme called <a href=\"https://en.wikipedia.org/wiki/ATP_citrate_lyase\" target=\"_blank\">ATP citrate lyase</a> (ACL) which plays a key role in cholesterol and fatty acid synthesis.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213791\" data-linked=\"Esperion adds patients on statin therapy to bempedoic acid&#39;s Phase 3 development program after positive Phase 2 results; shares up 11%\" data-tweet=\"$ESPR $ESPR $PFE - Esperion adds patients on statin therapy to bempedoic acid&#39;s Phase 3 development program after positive Phase 2 results; shares up 11% https://seekingalpha.com/news/3213791-esperion-adds-patients-on-statin-therapy-to-bempedoic-acids-phase-3-development-program-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3213791-esperion-adds-patients-on-statin-therapy-to-bempedoic-acids-phase-3-development-program-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213797\" data-ts=\"1476369218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213797-natural-gas-inventory-builds-in-last-week\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory builds in the last week</a></h4><ul>\n<li>\n<a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory</a>: <strong>+79</strong><strong> Bcf</strong> vs. +87 Bcf consensus, +80 Bcf last week.</li>\n<li>Futures <font color=\"green\">+2.15%</font> to $3.279.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/UNG\" title=\"The United States Natural Gas ETF, LP\">UNG</a>, <a href=\"https://seekingalpha.com/symbol/DGAZ\" title=\"VelocityShares 3x Inverse Natural Gas ETN\">DGAZ</a>, <a href=\"https://seekingalpha.com/symbol/UGAZ\" title=\"VelocityShares 3x Long Natural Gas ETN\">UGAZ</a>, <a href=\"https://seekingalpha.com/symbol/BOIL\" title=\"ProShares Ultra Bloomberg Natural Gas ETF\">BOIL</a>, <a href=\"https://seekingalpha.com/symbol/GAZ\" title=\"iPath DJ-UBS Natural Gas Total Return Sub-Index ETN\">GAZ</a>, <a href=\"https://seekingalpha.com/symbol/KOLD\" title=\"ProShares UltraShort Bloomberg Natural Gas ETF\">KOLD</a>, <a href=\"https://seekingalpha.com/symbol/UNL\" title=\"The United States 12 Month Natural Gas ETF, LP\">UNL</a>, <a href=\"https://seekingalpha.com/symbol/DCNG\" title=\"iPath Pure Beta Seasonal Natural Gas ETN\">DCNG</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213797\" data-linked=\"Natural gas inventory builds in the last week\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory builds in the last week https://seekingalpha.com/news/3213797-natural-gas-inventory-builds-in-last-week?source=tweet\" data-url=\"https://seekingalpha.com/news/3213797-natural-gas-inventory-builds-in-last-week\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213788\" data-ts=\"1476367800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMPV\" target=\"_blank\">IMPV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213788-imperva-lower-despite-continued-takeover-reports\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Imperva lower despite continued takeover reports</a></h4><ul><li>Thoma Bravo and Silver Lake Management were <a href=\"http://www.bloomberg.com/news/articles/2016-10-12/silver-lake-thoma-bravo-said-to-plan-takeover-bids-for-imperva\" target=\"_blank\">noted by Bloomberg</a> yesterday to be planning offers, with a new round of bids supposedly due next month.</li><li>IBM and Cisco Systems <a href=\"https://seekingalpha.com/news/3210468-imperva-plus-15-percent-hours-reported-ibm-cisco-interest-updated\" target=\"_blank\">were also said to be interested</a> in Imperva (NASDAQ:<a href='https://seekingalpha.com/symbol/IMPV' title='Imperva, Inc.'>IMPV</a>) back in September and are considered to remain so.</li><li>Though&nbsp;<font color='red'>down 2%</font>&nbsp;today, possibly attributable to an <a href=\"https://seekingalpha.com/news/3213491-cybersecurity-hit-hours-fortinets-q3-guidance-lowering\" target=\"_blank\">overall difficult week for cybersecurity</a>, Imperva shares have held around&nbsp;<font color='green'>15% gains</font>&nbsp;since the IBM, Cisco Systems (and Forcepoint,&nbsp;Akamai Technologies)&nbsp;reports began circulating on September 22.</li></ul><div class=\"tiny-share-widget\" data-id=\"3213788\" data-linked=\"Imperva lower despite continued takeover reports\" data-tweet=\"$IMPV - Imperva lower despite continued takeover reports https://seekingalpha.com/news/3213788-imperva-lower-despite-continued-takeover-reports?source=tweet\" data-url=\"https://seekingalpha.com/news/3213788-imperva-lower-despite-continued-takeover-reports\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213787\" data-ts=\"1476367754\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ULTA\" target=\"_blank\">ULTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213787-sparkling-guidance-lifts-ulta-beauty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sparkling guidance lifts Ulta Beauty</a></h4><ul> <li>Shares of Ulta Beauty (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ULTA\" title=\"Ulta Beauty, Inc.\">ULTA</a>) are racing higher after the company's analyst day presentation impresses.</li> <li>The company raised short-term and near-term guidance on a strong view of where its business is heading. Ulta Salon sees expanding to 1,700 stores in the U.S., while also growing same-store sales at a healthy clip.</li> <li>ULTA <font color=\"green\">+6.18%</font> to $253.74.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3213747-ulta-beauty-talks-strategy-guidance-analyst-day-event\" target=\"_blank\">Ulta Beauty talks strategy and guidance at analyst day event</a> (Oct. 13)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3213787\" data-linked=\"Sparkling guidance lifts Ulta Beauty\" data-tweet=\"$ULTA - Sparkling guidance lifts Ulta Beauty https://seekingalpha.com/news/3213787-sparkling-guidance-lifts-ulta-beauty?source=tweet\" data-url=\"https://seekingalpha.com/news/3213787-sparkling-guidance-lifts-ulta-beauty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213781\" data-ts=\"1476366990\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACHV\" target=\"_blank\">ACHV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213781-oncogenexs-custirsen-comes-up-short-in-late-stage-lung-cancer-study-shares-down-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OncoGenex&#39;s custirsen comes up short in late-stage lung cancer study; shares down 6%</a></h4><ul>\n<li>Thinly traded nano cap OncoGenex (OGXI <font color=\"red\">-6.3%</font>) eases in early trading after reporting <a href=\"https://www.sec.gov/Archives/edgar/data/949858/000119312516737163/d265965dex991.htm\" target=\"_blank\">failed results</a> from a Phase 3 clinical trial, ENSPIRIT, assessing lead product candidate custirsen, in combination with the chemo agent docetaxel, in patients with advanced non-small cell lung cancer (NSCLC) who had progressed after initial chemotherapy. The combination failed to demonstrate a statistically valid increase in median overall survival (OS) compared to docetaxel alone (9.0 months vs. 7.9 months; p=0.178).</li>\n<li>Two months ago, shares plummeted after the company reported failed results in another late-stage trial in treatment-resistant prostate cancer. The company is currently exploring strategic alternatives.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3203650-oncogenexs-custirsen-flunks-late-stage-study-prostate-cancer-shares-slump-34-percent\" target=\"_blank\">OncoGenex's custirsen flunks late-stage study in prostate cancer; shares slump 34% premarket</a> (Aug. 16)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213781\" data-linked=\"OncoGenex&#39;s custirsen comes up short in late-stage lung cancer study; shares down 6%\" data-tweet=\"$ACHV - OncoGenex&#39;s custirsen comes up short in late-stage lung cancer study; shares down 6% https://seekingalpha.com/news/3213781-oncogenexs-custirsen-comes-up-short-in-late-stage-lung-cancer-study-shares-down-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3213781-oncogenexs-custirsen-comes-up-short-in-late-stage-lung-cancer-study-shares-down-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213782\" data-ts=\"1476366572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPHI\" target=\"_blank\">IPHI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213782-stifel-positive-on-inphi-ahead-of-q3-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel positive on Inphi ahead of Q3 earnings</a></h4><ul>\n<li>Price target <a href=\"http://www.streetinsider.com/Analyst+Comments/Inphi+Corp.+%28IPHI%29%3A+100GData+Center+Trends+Remain+Positive+-+Stifel/12129315.html\" target=\"_blank\">raised</a> from $44 to $48 (current price $39.40), Buy rating reissued.</li>\n<li>Analyst Tore Svanberg anticipates results at the high-end of company guidance ($66.8M-$68.8M). Fundamentals and demand, particularly relating to data center business, cited.</li>\n<li>Inphi (<a href=\"https://seekingalpha.com/symbol/IPHI\" title=\"Inphi Corporation\">IPHI</a> <font color=\"red\">-1.8%</font>) is presently <font color=\"red\">lower by 10%</font> on the week, <font color=\"green\">up 18%</font> over the last three months and <font color=\"green\">up over 50%</font> on the year.</li>\n<li>\n<a href=\"http://investors.inphi.com/phoenix.zhtml?c=237726&amp;p=irol-newsArticle&amp;ID=2210936\" target=\"_blank\">To report</a> Q3 results on November 1.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213782\" data-linked=\"Stifel positive on Inphi ahead of Q3 earnings\" data-tweet=\"$IPHI - Stifel positive on Inphi ahead of Q3 earnings https://seekingalpha.com/news/3213782-stifel-positive-on-inphi-ahead-of-q3-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3213782-stifel-positive-on-inphi-ahead-of-q3-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213777\" data-ts=\"1476365811\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTX\" target=\"_blank\">PTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213777-pernix-to-reverse-split-shares-1-10-after-todays-close-shares-off-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pernix to reverse split shares 1:10 after today&#39;s close; shares off 15%</a></h4><ul><li>Nano cap Pernix Therapeutics (<a href='https://seekingalpha.com/symbol/PTX' title='Pernix Therapeutics Holdings, Inc.'>PTX</a> <font color='red'>-14.9%</font>) will execute a <a href=\"https://www.sec.gov/Archives/edgar/data/1024126/000113626116000626/body8k.htm\" target=\"_blank\">1:10 reverse split</a> of its common stock effective at the close of business today. Post-split trading will commence tomorrow.</li></ul><div class=\"tiny-share-widget\" data-id=\"3213777\" data-linked=\"Pernix to reverse split shares 1:10 after today&#39;s close; shares off 15%\" data-tweet=\"$PTX $PTX-OLD - Pernix to reverse split shares 1:10 after today&#39;s close; shares off 15% https://seekingalpha.com/news/3213777-pernix-to-reverse-split-shares-1-10-after-todays-close-shares-off-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3213777-pernix-to-reverse-split-shares-1-10-after-todays-close-shares-off-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213772\" data-ts=\"1476365306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGTX\" target=\"_blank\">TGTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213772-tg-therapeutics-backs-off-pfs-endpoint-in-late-stage-study-of-lead-product-candidate-tgminus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TG Therapeutics backs off PFS as an endpoint in late-stage study of lead product candidate TG-1101; shares slump 15% premarket</a></h4><ul>\n<li>Thinly traded micro cap TG Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TGTX\" title=\"TG Therapeutics, Inc.\">TGTX</a>) is down <font color=\"red\">15%</font> premarket on increased volume in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1001316/000165495416002790/v101316_ex99-1.htm\" target=\"_blank\">announcement </a>that it has filed a request with the FDA to amend the protocol in its Phase 3 study, GENUINE, assessing lead product candidate TG-1101 in patients with high-risk relapsed/refractory chronic lymphocytic leukemia (CLL).</li>\n<li>The amended protocol, if approved, will drop progression-free survival (PFS) as an efficacy endpoint (Part II of the study) with overall response rate (ORR) serving as the sole primary endpoint (Part I). Enrollment in the revised study should be completed this quarter with top-line data expected in H1 2017.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213772\" data-linked=\"TG Therapeutics backs off PFS as an endpoint in late-stage study of lead product candidate TG-1101; shares slump 15% premarket\" data-tweet=\"$TGTX - TG Therapeutics backs off PFS as an endpoint in late-stage study of lead product candidate TG-1101; shares slump 15% premarket https://seekingalpha.com/news/3213772-tg-therapeutics-backs-off-pfs-endpoint-in-late-stage-study-of-lead-product-candidate-tgminus?source=tweet\" data-url=\"https://seekingalpha.com/news/3213772-tg-therapeutics-backs-off-pfs-endpoint-in-late-stage-study-of-lead-product-candidate-tgminus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213770\" data-ts=\"1476364926\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DECK\" target=\"_blank\">DECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213770-deckers-brands-clipped-susquehanna-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deckers Brands clipped by Susquehanna downgrade</a></h4><ul> <li>Shares of Deckers Brands (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DECK\" title=\"Deckers Outdoor Corporation\">DECK</a>) are on watch after Susquehanna <a href=\"https://www.marketbeat.com/stocks/NYSE/DECK/\" target=\"_blank\">downgrades</a> the footwear stock to Negative from Neutral.</li> <li>Analyst Sam Poser warns on UGG sales after noting an elevated level of promotional activity for the cold-weather brand already.</li> <li>Susquehanna clips its price target to $49 from $59.</li> <li>Shares of Deckers are <font color=\"red\">down 5.15%</font> premarket to $57.84 vs. a 52-week trading range of $40.74 to $69.94.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213770\" data-linked=\"Deckers Brands clipped by Susquehanna downgrade\" data-tweet=\"$DECK - Deckers Brands clipped by Susquehanna downgrade https://seekingalpha.com/news/3213770-deckers-brands-clipped-susquehanna-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3213770-deckers-brands-clipped-susquehanna-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213769\" data-ts=\"1476364848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213769-premarket-gainers-losers-of-9-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:15 am</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/CARA' title='Cara Therapeutics Inc.'>CARA</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TGTX' title='TG Therapeutics, Inc.'>TGTX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/VAC' title='Marriott Vacations Worldwide Corp.'>VAC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MYGN' title='Myriad Genetics, Inc.'>MYGN</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/VOXX' title='VOXX International Corp.'>VOXX</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3213769\" data-linked=\"Premarket Gainers / Losers as of 9:15 am\" data-tweet=\"$HEPA $OCUL $CARA - Premarket Gainers / Losers as of 9:15 am https://seekingalpha.com/news/3213769-premarket-gainers-losers-of-9-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3213769-premarket-gainers-losers-of-9-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213768\" data-ts=\"1476364458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APTO\" target=\"_blank\">APTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213768-aptose-bio-not-quite-clinical-hold-on-lead-product-candidate-aptominus-253-shares-slump-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aptose Bio not quite there with clinical hold on lead product candidate APTO-253; shares slump 17% premarket</a></h4><ul>\n<li>Thinly traded nano cap Aptose Biosciences (NASDAQ:<a href=\"https://seekingalpha.com/symbol/APTO\" title=\"Aptose Biosciences Inc.\">APTO</a>) is down <font color=\"red\">17%</font> premarket on modest volume in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/882361/000117184316012447/exh_991.htm\" target=\"_blank\">announcement </a>that the FDA's clinical hold on its Phase 1b study assessing lead product candidate APTO-253 will remain in place until it submits additional data. The agency instituted the hold in November 2015 after problems with an IV infusion pump surfaced at a clinical trial site.</li>\n<li>The company submitted its formal responses to the FDA last month, but the agency has requested additional data are regarding the GMP-grade drug substance and drug product that will be used in the clinic. Aptose's data was collected using prototype batches of the active pharmaceutical ingredient (API) and drug product, but the drug substance was changed from a salt to a free base with the aim of eliminating filter clogging or pump stoppage during infusion. The change constituted a modification to the formulation which requires the submission of new data.</li>\n<li>\n<a href=\"http://aptose.com/apto-253/\" target=\"_blank\">APTO-253</a> is a small molecule that has shown potent anti-tumor activity in cancer cells via its induction of a gene that expresses proteins called <a href=\"https://en.wikipedia.org/wiki/Kruppel-like_factors\" target=\"_blank\">Kruppel-like factors</a>, specifically KLF4. When the KLF4 gene is induced, it up-regulates expression of a protein called p21 which leads to cell cycle arrest and apoptosis (cell death).</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2944106-aptose-bios-early-stage-study-lead-product-candidate-placed-clinical-hold-fda-shares-27\" target=\"_blank\">Aptose Bio's early-stage study of lead product candidate placed on clinical hold by FDA; shares down 27% premarket</a> (Nov. 20, 2015)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213768\" data-linked=\"Aptose Bio not quite there with clinical hold on lead product candidate APTO-253; shares slump 17% premarket\" data-tweet=\"$APTO - Aptose Bio not quite there with clinical hold on lead product candidate APTO-253; shares slump 17% premarket https://seekingalpha.com/news/3213768-aptose-bio-not-quite-clinical-hold-on-lead-product-candidate-aptominus-253-shares-slump-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3213768-aptose-bio-not-quite-clinical-hold-on-lead-product-candidate-aptominus-253-shares-slump-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213758\" data-ts=\"1476363139\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLDM\" target=\"_blank\">FLDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213758-fluidigm-down-22-premarket-on-revenue-shortfall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fluidigm down 22% premarket on revenue shortfall</a></h4><ul>\n<li>Thinly traded micro cap Fluidigm (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FLDM\" title=\"Fluidigm Corporation\">FLDM</a>) slumps <font color=\"red\">22%</font> premarket on average volume after it announced that preliminary Q3 revenues will be $22.2M, down almost 23% from a year ago and 24% shy of consensus.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3213653-fluidigm-reports-preliminary-q3-revenue-expectation-suspending-guidance\" target=\"_blank\">Fluidigm reports preliminary Q3 revenue below expectation; suspending guidance</a> (Oct. 12)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213758\" data-linked=\"Fluidigm down 22% premarket on revenue shortfall\" data-tweet=\"$FLDM - Fluidigm down 22% premarket on revenue shortfall https://seekingalpha.com/news/3213758-fluidigm-down-22-premarket-on-revenue-shortfall?source=tweet\" data-url=\"https://seekingalpha.com/news/3213758-fluidigm-down-22-premarket-on-revenue-shortfall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213754\" data-ts=\"1476362499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCUL\" target=\"_blank\">OCUL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213754-ocular-therapeutix-teams-up-regeneron-to-develop-sustained-release-formulation-of-aflibercept\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocular Therapeutix teams up with Regeneron to develop sustained-release formulation of aflibercept; shares ahead 28% premarket</a></h4><ul>\n<li>Micro cap Ocular Therapeutix (NASDAQ:<a href=\"https://seekingalpha.com/symbol/OCUL\" title=\"Ocular Therapeutix\">OCUL</a>) is up <font color=\"green\">28%</font> premarket on robust volume in response to its announcement of a strategic collaboration with Regeneron Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/REGN\" title=\"Regeneron Pharmaceuticals, Inc.\">REGN</a>) to develop a sustained-release formulation of aflibercept, marketed in the U.S. under the brand name EYLEA, for the treatment of wet age-related macular degeneration (wet AMD) and other retinal disorders.</li>\n<li>Under the terms of the agreement, Regeneron has the option to secure an exclusive license to Ocular's <a href=\"http://www.ocutx.com/pipeline/posterior-segment-sustained-release-injections\" target=\"_blank\">hydrogel-based technology</a> for a sustained-release formulation of aflibercept and other biologics targeting VEGF for ophthalmic indications. Ocular retains the rights to its platform for all other non-VEGF-targeting compounds in addition to small molecule drugs for other retinal diseases. If Regeneron exercises its option, Ocular will receive a $10M payment and will be responsible for Phase 1 development. Regeneron will be responsible for further development and commercialization. Ocular will be eligible to receive up to $305M in milestones and tiered royalties on net sales from high-single-digit to low-to-mid-teens.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213754\" data-linked=\"Ocular Therapeutix teams up with Regeneron to develop sustained-release formulation of aflibercept; shares ahead 28% premarket\" data-tweet=\"$OCUL $OCUL $REGN - Ocular Therapeutix teams up with Regeneron to develop sustained-release formulation of aflibercept; shares ahead 28% premarket https://seekingalpha.com/news/3213754-ocular-therapeutix-teams-up-regeneron-to-develop-sustained-release-formulation-of-aflibercept?source=tweet\" data-url=\"https://seekingalpha.com/news/3213754-ocular-therapeutix-teams-up-regeneron-to-develop-sustained-release-formulation-of-aflibercept\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213749\" data-ts=\"1476361202\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLKS\" target=\"_blank\">FLKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213749-flex-pharma-to-start-mid-stage-study-of-flxminus-787-for-treatment-of-nocturnal-leg-cramps-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flex Pharma to start mid-stage study of FLX-787 for the treatment of nocturnal leg cramps in H1 2017</a></h4><ul>\n<li>Thinly traded micro cap Flex Pharma (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FLKS\" title=\"Flex Pharma\">FLKS</a>) is down <font color=\"red\">17%</font> premarket, albeit on only 200 shares, after its announcement of its clinical development plan for FLX-787 for the treatment of nocturnal leg cramps (NLCs).</li>\n<li>Based on feedback from the FDA, the company plans a parallel design Phase 2 study which should commence in H1 2017 after its Investigational New Drug (IND) application has bee filed and accepted.</li>\n<li>Flex has stated that it expects to market FLX-787 as a dietary supplement for reducing NLCs. According to the company, its treatment stimulates the primary sensory neurons in the mouth, stomach and esophagus by activating transient receptor potential (TRP) cation channel receptors. In other words, the small molecule compound, acting topically, generates an electrical signal for therapeutic effect. TRP activators are recognized as safe by the FDA when used in food products so Flex originally did not expect to file an IND with the FDA, but this has clearly changed. FLX-787 is also being developed for the treatment of multiple sclerosis and amyotrophic lateral sclerosis.</li>\n<li>Management will host a conference call this morning at 8:45 am ET to discuss its plans.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213749\" data-linked=\"Flex Pharma to start mid-stage study of FLX-787 for the treatment of nocturnal leg cramps in H1 2017\" data-tweet=\"$FLKS $SLRX - Flex Pharma to start mid-stage study of FLX-787 for the treatment of nocturnal leg cramps in H1 2017 https://seekingalpha.com/news/3213749-flex-pharma-to-start-mid-stage-study-of-flxminus-787-for-treatment-of-nocturnal-leg-cramps-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3213749-flex-pharma-to-start-mid-stage-study-of-flxminus-787-for-treatment-of-nocturnal-leg-cramps-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213737\" data-ts=\"1476359389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRO\" target=\"_blank\">GPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213737-goprominus-3_85-pre-piper-says-amazon-ditched\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GoPro -3.85% pre; Piper says Amazon has ditched</a></h4><ul>\n<li>The company <a href=\"https://twitter.com/thenotablecalls/status/786528382427156480\" target=\"_blank\">has stopped shipping</a> to Amazon which represents 12-14% of sales, according to Piper Jaffray's Erinn Murphy. The revenue shortfall could be $100M. Management hopes to resume shipping to Amazon by the end of the month.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/GPRO\" title=\"GoPro\">GPRO</a> <font color=\"red\">-3.85%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213737\" data-linked=\"GoPro -3.85% pre; Piper says Amazon has ditched\" data-tweet=\"$GPRO - GoPro -3.85% pre; Piper says Amazon has ditched https://seekingalpha.com/news/3213737-goprominus-3_85-pre-piper-says-amazon-ditched?source=tweet\" data-url=\"https://seekingalpha.com/news/3213737-goprominus-3_85-pre-piper-says-amazon-ditched\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213736\" data-ts=\"1476359176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTRV\" target=\"_blank\">CTRV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213736-contravir-pharmas-cmx157-matches-gileads-viread-in-mid-stage-hbv-study-shares-ahead-38\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ContraVir Pharma&#39;s CMX157 matches Gilead&#39;s Viread in mid-stage HBV study; shares ahead 38% premarket</a></h4><ul>\n<li>Thinly traded nano cap ContraVir Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CTRV\" title=\"ContraVir Pharmaceuticals, Inc.\">CTRV</a>) is up <font color=\"green\">38% </font>premarket on average volume in response to its announcement of positive interim results from a Phase 2a multiple ascending dose study assessing CMX157 compared to Gilead Sciences' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a>) <a href=\"http://www.viread.com/\" target=\"_blank\">Viread </a>(tenofovir disoproxil fumarate or TDF) for the treatment of chronic hepatitis B virus (HBV) infection.</li>\n<li>Data from 10 HBV-positive patients who completed 14 days of once-daily dosing of 25 mg of CMX157 and two patients who received 300 mg of Viread once-daily for 14 days showed an average 99% reduction in HBV viral load compared to baseline.</li>\n<li>After a four-week dosing regimen and independent safety review are completed, dose escalation will continue at the 50 mg and 100 mg levels.</li>\n<li>The company says the comparable efficacy at 1/12th the dose of Viread is a major advantage due the reduced risk of unwanted side effects.</li>\n<li>\n<a href=\"http://contravir.com/cmx157/\" target=\"_blank\">CMX157 </a>is a novel lipid <a href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC207110/\" target=\"_blank\">acyclic nucleoside phosphonate</a> (same class as tenofovir) that delivers high intracellular concentrations of tenofovir diphosphate. </li>\n<li>The company is playing catch-up to Gilead's TAF, however. Its marketing application is currently under FDA review with an action date of November 11. In clinical studies, TAF showed equivalence to TDF at 1/10th the dose of TDF.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3173309-complete-data-two-late-stage-studies-show-gileads-taf-matches-tdf-hbv-patients-regardless-e\" target=\"_blank\">Complete data from two late-stage studies show Gilead's TAF matches TDF in HBV patients regardless of e-antigen status</a> (April 15)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213736\" data-linked=\"ContraVir Pharma&#39;s CMX157 matches Gilead&#39;s Viread in mid-stage HBV study; shares ahead 38% premarket\" data-tweet=\"$CTRV $HEPA $GILD - ContraVir Pharma&#39;s CMX157 matches Gilead&#39;s Viread in mid-stage HBV study; shares ahead 38% premarket https://seekingalpha.com/news/3213736-contravir-pharmas-cmx157-matches-gileads-viread-in-mid-stage-hbv-study-shares-ahead-38?source=tweet\" data-url=\"https://seekingalpha.com/news/3213736-contravir-pharmas-cmx157-matches-gileads-viread-in-mid-stage-hbv-study-shares-ahead-38\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213731\" data-ts=\"1476357872\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UN\" target=\"_blank\">UN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213731-unilever-and-tesco-in-scrap-over-higher-prices-in-u-k\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Unilever and Tesco in scrap over higher prices in U.K.</a></h4><ul> <li>Unilever (<a href=\"https://seekingalpha.com/symbol/UN\" title=\"Unilever NV\">UN</a>, <a href=\"https://seekingalpha.com/symbol/UL\" title=\"Unilever Plc\">UL</a>) says it was forced to push through prices increases in the U.K. due to the devaluation of the pound after the Brexit vote.</li> <li>\"The price increases have landed with most of our customers,\" notes CFO Graeme Pitkethly.</li> <li>Unilever is in a bit of a scrap with Tesco (<a href=\"https://seekingalpha.com/symbol/TSCDF\" title=\"Tesco PLC\">OTCPK:TSCDF</a>, <a href=\"https://seekingalpha.com/symbol/TSCDY\" title=\"Tesco PLC ADR\">OTCPK:TSCDY</a>) over the higher pricing, halting supplies to the grocery chain until the raised prices are posted.</li>\n<li>Unilever ADRs are <font color=\"red\">down 2.30%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3213731\" data-linked=\"Unilever and Tesco in scrap over higher prices in U.K.\" data-tweet=\"$UN $UN $UL - Unilever and Tesco in scrap over higher prices in U.K. https://seekingalpha.com/news/3213731-unilever-and-tesco-in-scrap-over-higher-prices-in-u-k?source=tweet\" data-url=\"https://seekingalpha.com/news/3213731-unilever-and-tesco-in-scrap-over-higher-prices-in-u-k\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213730\" data-ts=\"1476357844\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WGO\" target=\"_blank\">WGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213730-on-winnebagos-fq4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Winnebago&#39;s FQ4</a></h4><ul>     <li>Winnebago (NYSE:<a href=\"https://seekingalpha.com/symbol/WGO\" title=\"Winnebago Industries, Inc.\">WGO</a>) reports revenue rose 4.9% in FQ4 due to higher shipments of 3.0% in motorized units and 57.5% in towables.</li>     <li>Gross margin improved 90 bps to 12.1% due to lower raw material costs resulting from the Company\u2019s strategic sourcing initiative, as well as favorable product mix and lower warranty expense.</li>     <li>Operating margin rate expanded 50 bps to 7.2%.</li>     <li>Total motor homes deliveries +3% Y/Y to 2,436.</li>     <li>Total towable deliveries +57.5% Y/Y to 1,224.</li>     <li>Dealer inventory: Motor homes +6.7% to 4,345; Towables +29.6% to 2,156.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3213730\" data-linked=\"More on Winnebago&#39;s FQ4\" data-tweet=\"$WGO - More on Winnebago&#39;s FQ4 https://seekingalpha.com/news/3213730-on-winnebagos-fq4?source=tweet\" data-url=\"https://seekingalpha.com/news/3213730-on-winnebagos-fq4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3213729\" data-ts=\"1476357596\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3213729-modest-selloff-in-u-s-futures\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Modest selloff in U.S. futures</a></h4><ul>\n<li>Some weak economic numbers out of China makes for a good excuse for headline writers. The country's exports took a 10% dive in September, suggesting weaker-than-hoped global economic strength. Shanghai was little-changed overnight, but the Hang Seng <font color=\"red\">fell 1.6%</font>. The Nikkei <font color=\"red\">dropped 1.15%</font>.</li>\n<li>Europe's <font color=\"red\">down almost 1%</font> at midday, and U.S. futures are <font color=\"red\">lower by about 0.5% </font>across the board.</li>\n<li>The 10-year Treasury yield is down 3 basis points to 1.74%, and gold/oil are little-changed.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/SPY\" title=\"SPDR S&amp;P 500 Trust ETF\">SPY</a>, <a href=\"https://seekingalpha.com/symbol/QQQ\" title=\"PowerShares QQQ Trust ETF\">QQQ</a>, <a href=\"https://seekingalpha.com/symbol/DIA\" title=\"SPDR Dow Jones Industrial Average ETF\">DIA</a>, <a href=\"https://seekingalpha.com/symbol/SH\" title=\"ProShares Short S&amp;P 500 ETF\">SH</a>, <a href=\"https://seekingalpha.com/symbol/SSO\" title=\"ProShares Ultra S&amp;P 500 ETF\">SSO</a>, <a href=\"https://seekingalpha.com/symbol/VOO\" title=\"Vanguard S&amp;P 500 ETF\">VOO</a>, <a href=\"https://seekingalpha.com/symbol/SDS\" title=\"ProShares UltraShort S&amp;P 500 ETF\">SDS</a>, <a href=\"https://seekingalpha.com/symbol/IVV\" title=\"iShares Core S&amp;P 500 ETF\">IVV</a>, <a href=\"https://seekingalpha.com/symbol/SPXU\" title=\"ProShares UltraPro Short S&amp;P 500 ETF\">SPXU</a>, <a href=\"https://seekingalpha.com/symbol/TQQQ\" title=\"ProShares UltraPro QQQ ETF\">TQQQ</a>, <a href=\"https://seekingalpha.com/symbol/UPRO\" title=\"ProShares UltraPro S&amp;P 500 ETF\">UPRO</a>, <a href=\"https://seekingalpha.com/symbol/PSQ\" title=\"ProShares Short QQQ ETF\">PSQ</a>, <a href=\"https://seekingalpha.com/symbol/SPXL\" title=\"Direxion Daily S&amp;P 500 Bull 3x Shares ETF\">SPXL</a>, <a href=\"https://seekingalpha.com/symbol/RSP\" title=\"Guggenheim S&amp;P 500 Equal Weight ETF\">RSP</a>, <a href=\"https://seekingalpha.com/symbol/SPXS\" title=\"Direxion Daily S&amp;P 500 Bear 3x Shares ETF\">SPXS</a>, <a href=\"https://seekingalpha.com/symbol/SQQQ\" title=\"ProShares UltraPro Short QQQ ETF\">SQQQ</a>, <a href=\"https://seekingalpha.com/symbol/QID\" title=\"ProShares UltraShort QQQ ETF\">QID</a>, <a href=\"https://seekingalpha.com/symbol/DOG\" title=\"ProShares Short Dow 30 ETF\">DOG</a>, <a href=\"https://seekingalpha.com/symbol/QLD\" title=\"ProShares Ultra QQQ ETF\">QLD</a>, <a href=\"https://seekingalpha.com/symbol/DXD\" title=\"ProShares UltraShort Dow30 ETF\">DXD</a>, <a href=\"https://seekingalpha.com/symbol/UDOW\" title=\"ProShares UltraPro Dow 30 ETF\">UDOW</a>, <a href=\"https://seekingalpha.com/symbol/RWL\" title=\"RevenueShares Large Cap ETF\">RWL</a>, <a href=\"https://seekingalpha.com/symbol/SDOW\" title=\"ProShares UltraPro Short Dow 30 ETF\">SDOW</a>, <a href=\"https://seekingalpha.com/symbol/VFINX\" title=\"Vanguard 500 Index Fund Inv\">VFINX</a>, <a href=\"https://seekingalpha.com/symbol/EPS\" title=\"WisdomTree Earnings 500 ETF\">EPS</a>, <a href=\"https://seekingalpha.com/symbol/DDM\" title=\"ProShares Ultra Dow 30 ETF\">DDM</a>, <a href=\"https://seekingalpha.com/symbol/QQEW\" title=\"First Trust NASDAQ-100 Equal Weight Index ETF\">QQEW</a>, <a href=\"https://seekingalpha.com/symbol/BXUB\" title=\"Barclays Capital Long B Leveraged Exchange Traded Notes Linked to the S&amp;P 500® Total Return Index\">BXUB</a>, <a href=\"https://seekingalpha.com/symbol/QQQE\" title=\"Direxion NASDAQ-100 Equal Weighted Index Shares ETF\">QQQE</a>, <a href=\"https://seekingalpha.com/symbol/SPLX\" title=\"UBS ETRACS Monthly Reset 2xLeveraged S&amp;P 500 total Return ETN\">SPLX</a>, <a href=\"https://seekingalpha.com/symbol/SFLA\" title=\"iPath Long Extended 3x S&amp;P 500 Index TR Index ETN\">SFLA</a>, <a href=\"https://seekingalpha.com/symbol/BXUC\" title=\"Barclays Capital Long C Leveraged Exchange Traded Notes Linked to the S&amp;P 500® Total Return Index\">BXUC</a>, <a href=\"https://seekingalpha.com/symbol/QQXT\" title=\"First Trust Nasdaq-100 Ex-Tech Sector Index ETF\">QQXT</a>, <a href=\"https://seekingalpha.com/symbol/SPUU\" title=\"Direxion Daily S&amp;P 500 Bull 2x Shares ETF\">SPUU</a>, <a href=\"https://seekingalpha.com/symbol/SPXE\" title=\"ProShares S&amp;P 500 Ex-Energy ETF\">SPXE</a>, <a href=\"https://seekingalpha.com/symbol/LLSP\" title=\"Direxion Daily S&amp;P 500 Bull 1.25X Shares\">LLSP</a>, <a href=\"https://seekingalpha.com/symbol/UDPIX\" title=\"ProFunds Ultra Dow 30 ProFund Inv\">UDPIX</a>, <a href=\"https://seekingalpha.com/symbol/OTPIX\" title=\"ProFunds NASDAQ-100 Fund Inv\">OTPIX</a>, <a href=\"https://seekingalpha.com/symbol/RYARX\" title=\"Rydex Inverse S&amp;P 500® Strategy Fund A\">RYARX</a>, <a href=\"https://seekingalpha.com/symbol/SPXN\" title=\"ProShares S&amp;P 500 Ex-Financial ETF\">SPXN</a>, <a href=\"https://seekingalpha.com/symbol/SPDN\" title=\"Direxion Daily S&amp;P 500 Bear 1x Shares ETF\">SPDN</a>, <a href=\"https://seekingalpha.com/symbol/SPXT\" title=\"ProShares S&amp;P 500 Ex-Technology ETF\">SPXT</a>, <a href=\"https://seekingalpha.com/symbol/SPXV\" title=\"ProShares S&amp;P 500 Ex-Health Care ETF\">SPXV</a>, <a href=\"https://seekingalpha.com/symbol/TALL\" title=\"RBC S&amp;P 500 Trend Allocator Index ETN\">TALL</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3213729\" data-linked=\"Modest selloff in U.S. futures\" data-tweet=\"$SPY $QQQ $DIA - Modest selloff in U.S. futures https://seekingalpha.com/news/3213729-modest-selloff-in-u-s-futures?source=tweet\" data-url=\"https://seekingalpha.com/news/3213729-modest-selloff-in-u-s-futures\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":60,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}